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ABSTRACT OF DISSERTATION

THERAPEUTIC VIDEO GAMES
AND THE SIMULATION OF EXECUTIVE FUNCTION DEFICITS IN ADHD
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental
disorder characterized by difficulty paying attention, impulsivity, and hyperactivity.
Diagnosis of ADHD rose 42% from 2003–2004 to 2011–2012. In 2011, 3.5 million
children were treated with drugs. Optimizing therapy can take a year, and may not be
completely effective.
A clinical trial is currently being conducted of a device/drug combination using the
computer game Minecraft, to determine how certain activities affect executive function,
working memory, and restraint in patients diagnosed with ADHD. The human subjects’
responses are being modeled using artificial neural networks (ANNs), an artificial
intelligence method that can be utilized to interpret highly complex data. We propose using
ANNs to optimize drug and Minecraft therapy for individual patients based on the initial
NICHQ Vanderbilt assessment scores. We are applying ANNs in the development of
computational models for executive function deficiencies in ADHD. These models will
then be used to develop a therapeutic video game as a drug/device combination with
stimulants for the treatment of ADHD symptoms in Fragile X Syndrome.
As a first step towards the design of virtual subjects with executive function
deficits, computational models of the core executive functions working memory and fluid
intelligence were constructed. These models were combined to create healthy control and
executive function-deficient virtual subjects, who performed a Time Management task
simulation that required the use of their executive functions to complete. The preliminary
working memory model utilized a convolutional neural network to identify handwritten
digits from the MNIST dataset, and the fluid intelligence model utilized a basic recurrent
neural network to produce sequences of integers in the range 1-9 that can be multiplied
together to produce the number 12. A simplified Impulsivity function was also included in
the virtual subject as a first step towards the future inclusion of the core executive function
inhibition.
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neural networks
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CHAPTER 1. BACKGROUND
1.1

Executive Functions

Executive functions are a set of effortful, top-down mental processes that govern
attention and regulate behavior1. Executive functions enable both visualization of the future
and remembrance of the past, allowing for control of one’s behavior over time to
accomplish long-term goals and self-reflection to recognize past mistakes so that they are
not repeated. In addition to the consideration of behavior across time, executive functions
also enable conscious manipulation of thoughts and ideas, which includes the use of
creativity to combine conflicting ideas in novel ways.
A set of core executive functions has been proposed to serve as a foundation for
higher order executive functions and the general application of executive functioning in
life activities1. These core executive functions include working memory, inhibitory control,
and cognitive flexibility. Fluid intelligence is a higher order executive function that
requires the use of the core executive functions for its execution. Application of the
executive functions allows for the development and use of important skills such as time
management, organization, planning, self-regulation, sustained attention, and
metacognition.
Working memory and inhibition are described as distinct core executive functions,
but work together very closely1. Working memory is the ability to hold a piece of
information in consciousness (short-term memory) and then manipulate it in some way2.
Inhibitory control includes the ability to ignore environmental distractions (attentional
control3 as well as the ability to prevent automatic or impulsive thoughts and behaviors
when they may not be appropriate. The inhibitory control of automatic thoughts,
particularly thoughts resulting from previous experiences that may interfere with
appropriate responses to present circumstances4 is of interest in this project. When working
memory is active, attention focuses on the information present in short-term memory,
which precludes the capture of this attention by unproductive thoughts and supports their
inhibition. Likewise, when inhibition is actively preventing the intrusion of distracting
thoughts, a greater degree of attention remains free for the use of working memory.
Cognitive flexibility5 includes the ability to change perspectives and adjust
accordingly when situational changes arise, and may be conceptualized as the combined
use of working memory and inhibition1. For example, when one attempts to change
perspectives the old perspective may continue to intrude as the individual effortfully
focuses their attention on the consideration of the new perspective. Thus, cognitive
flexibility in this case requires the use of inhibition to prevent the focus of attention on the
old perspective while the use of working memory shifts these attentional resources towards
the consideration of a new perspective.
Fluid intelligence is the use of adaptive reasoning in novel situations6. For the
purposes of this project fluid intelligence is considered as a problem solving ability
consisting of the mental processes analysis and synthesis7. Analysis is the deconstruction
of a complex idea into simpler pieces, whereas synthesis is the combining of simpler ideas
1

in various ways to construct larger, complex ideas. A pertinent example of the use of fluid
intelligence is in the practice of time management. When considering how to complete a
complex task most efficiently, one may first analyze the task carefully to determine the
individual steps needed for its completion. There will be a finite number of ways to
organize these steps, and the best sequence of steps will be the one that produces the best
outcome in the shortest amount of time. Working memory and the synthesis process of
fluid intelligence can be used to mentally rehearse the completion of varying combinations
of these steps and determine the time required to complete them. Some combinations of
steps may overlap better in time than others when they are completed sequentially, and
some steps may be found to provide minimal contributions to the overall goal. The order
of the overlapping steps may then be preserved in the final sequence, and the marginally
important steps may be left at the end of the sequence to be completed after the more highly
prioritized steps should time permit. In this way, fluid intelligence can work together with
the core executive function working memory in a time management activity.
As will be explained in detail later, a central component of this project is the
construction of computational models that simulate the use of executive functions in virtual
tasks designed to resemble real-life activities that train executive functions. In the initial
computational model described here, simplified representations of working memory and
the synthesis component of fluid intelligence were combined to create a virtual time
management activity. In lieu of behaviors being chosen and combined to complete a goal
in the most efficient manner as described above, integers between 1 and 10 were chosen
and combined to produce the larger integer 12. Working memory is represented here by
the identification of integers that are contained in image files of handwritten digits in the
MNIST dataset8. As a first step towards building a representation of inhibitory control, an
impulsivity function that interferes with the use of the working memory handwritten digit
identification function is included. Finally, the synthesis process of fluid intelligence is
represented by the combining of integers into sequences to produce the number 12.
The construction of a set of virtual executive function activities that represent reallife executive function training activities in human subjects could enable the rapid
computational simulation of different schedules of these activities. If a virtual set of
activities can be designed to resemble the use of human executive functions closely
enough, the simulations could potentially provide insight into how variations in the
selection and scheduling of these activities affect the outcomes of executive function
training in humans. Combinations of these activities the selection of an optimal schedule
of activities to improve executive function deficits in humans. In this way, an effective
virtual simulation model of executive function training activities could provide
considerable time and cost savings compared to clinical studies for the optimization of
training activity schedules in humans.
1.2

Artificial Neural Networks

Artificial neural networks (ANNs) are a group of computational models that are
inspired by the structure and function of biological neural networks9. ANNs are composed
of individual units that receive inputs, process these inputs, and produce an output, similar
2

to the way that individual neurons in biological neural networks receive, process, and
produce electrical signals. Multiple units are combined into layers, and these layers are
combined to form the full network. Each unit in a given layer receives multiple inputs
produced by units in the previous layer, and produces a single output that is used as an
input for multiple units in the next layer. The design of the units, layers, and their
connectivity pattern is known as the network architecture.
A single unit in an ANN consists of a set of parameters called weights and biases,
a transfer function, and an activation function (Figure 1)9. Each unit possesses multiple
weights (one for each input it receives), and a single bias value. The transfer function uses
the unit’s weights and biases to combine a unit’s multiple inputs into a single net input
value. The weights may be thought of as values that assign an importance to each input a
unit receives, similar to the way that the strength of a neural synapse determines the
influence that the outputs of a presynaptic neuron exert on a postsynaptic neuron. The bias
parameter is included to allow a unit to produce an output in the absence of any inputs. A
common transfer function uses an operation called the dot product to multiply each input
by its corresponding weight parameter, and then sum these weighted inputs together. The
bias value is then added to this sum to produce a single net input value for the unit, which
is processed by the activation function to determine the output of the unit.
ANNs have attracted interest as a computational model in drug development and
healthcare because of their ability to learn how to accomplish tasks that involve the
processing of complex input data. For example, ANNs have been used to predict the
quantitative structure-activity relationships of potential drug candidates10, predict the
occurrence of cardiovascular disease11, and screen for skin cancer12, diabetic retinopathy13,
and other retinal diseases.14 This automation of complex tasks requiring specialized
knowledge offers a significant potential advantage in time and cost savings.
Before an ANN is able to perform a task effectively, it must first learn how to perform the
task by completing a training procedure9. ANNs are part of a broader collection of
computational techniques called machine learning algorithms, which are a set of
computational models that learn how to complete tasks more accurately by performing the
tasks on their own without explicit guidance from a human15. Machine learning methods
are advantageous in that they allow for the automation of complex procedures where a
model can learn how to perform a task on its own without explicit instructions for how to
do so. There are three categories of training procedures: reinforcement learning,
unsupervised learning, and supervised learning. While unsupervised and supervised
learning involve the performance of a task on only a single example of training data at a
given time, reinforcement learning involves the performance of multiple sequential actions
within a complex environment to maximize total rewards. In reinforcement learning, the
environment consists of a series of different states presented to the model (or “agent”) as
inputs, where the agent makes a decision at each unique state and each decision is
associated with a unique reward value16. After the initial step, each new state depends on
the actions taken in the previous states, and each state may have a unique set of rewards
associated with the possible decisions in the state. In this context, the agent is trained to
make the best series of decisions as it proceeds through each state of the environment to
maximize the total reward value received. A simple application of reinforcement learning
is training an ANN to navigate a maze, and reinforcement learning techniques are of
3

Figure 1 – Structure of a computational unit in an Artificial Neural Network17

4

interest for developing navigation systems for autonomous vehicles18.
In contrast to learning how to make multiple decisions in response to a series of
related states with reinforcement learning, the models for unsupervised learning and
supervised learning learn how to make single unrelated decisions in response to distinct,
but possibly similar, inputs. Unsupervised and supervised learning differ in the quantity of
information available with the training examples. In unsupervised learning, the training
examples are presented without any information describing the correct response associated
with them19. Clustering algorithms are an example of a computational technique using
unsupervised learning. In clustering algorithms, data points are grouped into categories
based on similarities in their features. The relevant features of the data points are not known
in advance, and therefore the clustering algorithm must group the data points without any
guidance for how to do so.
In contrast, supervised learning training procedures include information about the
correct response for a training example during its presentation to the ANN20 (Figure 2). In
this case, the correct response (or training label) associated with a training example acts as
a feedback mechanism to adjust the ANN’s performance on the task. The accuracy of an
ANN’s response to a training example is determined by the ANN’s loss function, which
measures the deviation between the ANN’s output and the correct response. The output of
the loss function passes through each layer of the ANN in reverse order by the calculation
of partial derivatives in a technique called backpropagation21. Eventually, backpropagation
calculates the effect that all the weights and biases in the ANN exert on the loss function,
and this result is used to adjust the values of each weight and bias in a manner that nudges
the ANN’s response to a training example closer to the correct response indicated in the
training label.
A relatively simple variety of ANNs is a fully-connected feedforward network22
(Figure 3). As its name implies, the fully-connected feedforward network possesses a full
set of connections between each layer of units. In other words, each unit in a given layer
receives an input from every unit in the preceding layer, and its output is passed on to every
unit in the next layer. The term “feedforward” refers to the unidirectional forward flow of
information through the ANN.
An autoassociative memory network is a fully-connected feedforward network that
is trained to reproduce the input data it receives as an output23-24. These networks are trained
by supervised Hebbian learning, which is a variety of synaptic connection between two
neurons when both neurons are activated in close succession25. Since it is able to produce
a representation of an input that may be retained after the input is removed, the
autoassociative memory network can potentially perform the short-term memory function
of working memory within the scope of this project.

5

Figure 2 – The Supervised Learning Process for Artificial Neural Networks26
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Figure 3 – Structure of a Fully-Connected Artificial Neural Network27
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Another variety of feedforward network that does not possess a fully-connected
structure is the convolutional neural network (CNN)28. A CNN is constructed from
alternating convolutional and pooling layers. The convolutional layers consist of a set of
sliding filters that learn how to detect relevant features in that layer’s input data. Each unit
in a convolutional layer uses a filter to detect a feature in a sub-region of the input data,
and therefore is not fully connected to the outputs of the previous layer. Each unit in a
pooling layer in turn connects to a sub-region of the output of its preceding convolutional
layer, and compresses all the values contained in this sub-region into a single value. The
design of CNNs is inspired by the structure and function of the visual cortex, making them
particularly useful for analyzing visual information. In this project, CNNs are utilized to
serve as a representation for the information manipulation function of working memory.
The varieties of ANNs discussed thus far are only capable of processing a single
input at a time. A recurrent neural network (RNN)29, on the other hand, is capable of
processing multiple inputs (or sequences) at one time. While an RNN uses a feedforward
network structure to process the individual inputs in the sequence, it possesses a unique set
of weight and bias values that define a distinct internal layer for each input in the sequence.
A basic RNN determines the values of each internal layer from the values of the previous
internal layer by a process called matrix multiplication. This procedure is limited in its
usefulness for longer sequences of inputs, however, so an RNN called a Long Short-Term
Memory network (LSTM)30 includes a set of gates between internal layers that allows for
the “forgetting” of irrelevant information and improved performance.
Due to their similarity to biological neural networks, ANNs could potentially be
used as a computational model for neurological activity. This premise inspired the selection
of ANNs as a computational tool to simulate the training of executive functions in this
project. Importantly, the neurological activities of interest in this project are the neural
adaptations that occur during learning processes, rather than the actual function of neurons
during mental processes. It is hypothesized that ANNs can be trained to perform virtual
tasks that resemble activities in humans that require the use of executive functions, and that
this training process can provide insight into the optimal way to train the use of executive
functions in humans.
1.3

Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder is a neurodevelopmental disorder
characterized by inattention, hyperactivity, and impulsivity31. The onset of ADHD
typically occurs by 3 years of age, and must occur by 12 years of age for a diagnosis. While
symptom severity decreases with age, ADHD may persist into adulthood32, when the
hyperactive-impulsive symptoms typically subside but the inattentive symptoms persist33.
The American Psychiatric Association’s Diagnostic and Statistical Manual, Fifth Edition
(DSM-5) has identified three ADHD subtypes: predominantly inattentive, predominantly
hyperactive-impulsive, and combined type. Diagnosis of the predominantly inattentive and
predominantly hyperactive/impulsive subtypes requires the presence of at least six of their
respective symptoms (listed below) for at least six months. These symptoms must be
8

present in at least two settings, and cause clinically significant distress or impairment in
social, academic, or occupational functioning34. The combined subtype requires the
presence of at least six symptoms from both the predominantly inattentive and
predominantly hyperactive/impulsive subtypes for at least six months.
Inattentive Symptoms:
● Often fails to give close attention to details or makes careless mistakes in
schoolwork, at work, or during other activities (e.g., overlooks or misses details,
work is inaccurate).
● Often has difficulty sustaining attention in tasks or play activities (e.g., has
difficulty remaining focused during lectures, conversations, or lengthy reading).
● Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere,
even in the absence of any obvious distraction).
● Often does not follow through on instructions and fails to finish schoolwork,
chores, or duties in the workplace (e.g., starts tasks but quickly loses focus and is
easily sidetracked).
● Often has difficulty organizing tasks and activities (e.g., difficulty managing
sequential tasks; difficulty keeping materials and belongings in order; messy,
disorganized work; has poor time management; fails to meet deadlines).
● Often avoids, dislikes, or is reluctant to engage in tasks that require sustained
mental effort (e.g., schoolwork or homework; for older adolescents and adults,
preparing reports, completing forms, reviewing lengthy papers).
● Often loses things necessary for tasks or activities (e.g., school materials, pencils,
books, tools, wallets, keys, paperwork, eyeglasses, mobile telephones).
● Is often easily distracted by extraneous stimuli (for older adolescents and adults,
may include unrelated thoughts).
● Is often forgetful in daily activities (e.g., doing chores, running errands; for older
adolescents and adults, returning calls, paying bills, keeping appointments).
Hyperactive/Impulsive Symptoms:
● Often fidgets with or taps hands or feet or squirms in seat.
● Often leaves seat in situations when remaining seated is expected (e.g., leaves his
or her place in the classroom, in the office or other workplace, or in other situations
that require remaining in place).
● Often runs about or climbs in situations where it is inappropriate. (Note: In
adolescents or adults, may be limited to feeling restless.)
● Often unable to play or engage in leisure activities quietly.
● Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or
uncomfortable being still for extended time, as in restaurants, meetings; may be
experienced by others as being restless or difficult to keep up with).
9

● Often talks excessively.
● Often blurts out an answer before a question has been completed (e.g., completes
people’s sentences; cannot wait for turn in conversation).
● Often has difficulty waiting his or her turn (e.g., while waiting in line).
● Often interrupts or intrudes on others (e.g., butts into conversations, games, or
activities; may start using other people’s things without asking or receiving
permission; for adolescents and adults, may intrude into or take over what others
are doing).
Both the number of children diagnosed with ADHD and the use of stimulant
medications for its treatment has been rising in recent years. The overall prevalence of
ADHD increased from 6.1% in 1997-1998 to 10.2% in 2015-2016. The prevalence in boys
increased from 9.0% to 14.0%, while the prevalence in girls more than doubled from 3.1%
to 6.3%. However, it is unknown at this time whether these increases reflect the actual
number of ADHD cases, or are instead a result of factors leading to increased diagnosis of
ADHD, such as increased physician awareness, changes in diagnostic criteria, or increased
access to medical care35. In 2011, 3.5 million children were being treated with stimulants
according to parents36. In addition, prescriptions for ADHD meds in women of childbearing age increased by 344% from 2003 to 2015, which included a 700% increase in
women of ages 25-29 years and a 560% increase in women of age 30-34 years37.
The causes of ADHD remain largely unknown, although environmental factors and
genetic risk factors are known to be involved. Potential environmental risk factors for the
development of ADHD include fetal development, diet, and family interactions38. The risk
factors related to fetal development include prenatal smoking39, premature birth40, and low
birth weight41. However, the increased risk due to prenatal smoking may be due to other
environmental confounders38, and the increased risk observed from premature birth may
actually be due to the low birth weight of children who are born preterm41. Dietary risk
factors include deficiencies in fatty acids42, zinc43, and iron44, as well as the intake of
artificial food colorings45. The observed nutritional deficiencies may be due to altered
nutrient metabolism in children with ADHD rather than dietary intake, however46. Finally,
risk factors related to family interactions include parenting behaviors and early deprivation
and neglect38. Although difficult family environments and adverse parenting behaviors
have been associated with ADHD47-49, it remains uncertain whether these risk factors are
actually a causative factor of ADHD, or whether they result from the behavior of children
with ADHD38. However, early deprivation and neglect50 has shown stronger evidence of a
causative role.
Factors that protect against negative outcomes in children with ADHD have also
been identified, although this area of research is relatively recent so the scope of findings
is limited (for review, see Ref. 51). These factors are psychosocial, and can be classified
as personal factors, family factors, and social factors. Coping self-efficacy52, a sense of
competence51, and a sense of optimism and control53 are personal factors that protect
against negative outcomes in ADHD. Family factors include family cohesion54, parenting
style55-56, parenting skill57, and parental affection58-59. Social factors include friendship
presence60, friendship intimacy61, and peer acceptance51,62. The effects of these factors have
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been discovered in cross sectional studies and longitudinal studies of limited duration51, so
the long-term persistence of the protective effects over time has not yet been established.
With an estimated heritability rate of 0.763, genetic influences also play a
considerable role in the development of ADHD. Investigations into genetic factors of
ADHD have so far revealed modest associations for the dopamine transporter (DAT1),
dopamine receptors D4 & D5 (DRD4, DRD4), and the serotonin transporter (5HTT)64.
Therefore, many other unknown genetic variants likely interact with these genes to produce
the observed large heritability rate65.
Pharmacologic therapies are widely used to treat ADHD and have proven effective
in controlling ADHD symptoms. The most commonly used pharmacologic treatments
include stimulants (methylphenidate and amphetamine salts), a norepinephrine reuptake
inhibitor (atomoxetine), and alpha-2 adrenergic agonists (clonidine and guanfacine)66. Of
these, stimulants are the most efficacious and are recommended for use as the first-line
treatment option66. Stimulants increase release of the neurotransmitters norepinephrine and
dopamine release into neuronal synapses, primarily from binding to the dopamine
transporter (DAT1)67. DAT1 is a membrane protein located in the presynaptic terminal of
dopaminergic neurons, and terminates the action of dopamine and norepinephrine on
postsynaptic neurons by transferring them from the neural synapse back into presynaptic
nerve terminals68. While methylphenidate binding inhibits DAT1’s reuptake activity,
amphetamine reverses the direction of DAT1’s neurotransmitter transport function. In
other words, methylphenidate prevents removal of dopamine and norepinephrine from the
synapse, while amphetamine both prevents the removal of dopamine and norepinephrine
and increases its release from the presynaptic neuron via reversed function of DAT1. In
addition, amphetamine displaces dopamine and norepinephrine from synaptic vesicles to
increase their available cytosolic concentration for reverse transport by DAT1 into the
synapse. The overall effect of stimulants is to increase synaptic levels of dopamine and
norepinephrine, and increase their availability for signaling to post-synaptic neurons.
Atomoxetine binds to and inhibits the function of the norepinephrine transporter
protein, which removes norepinephrine from neuronal synapses in a manner similar to
DAT1’s uptake of dopamine67. Alpha-2 adrenergic agonists enhance the action of the
alpha-2 G-protein coupled receptor located in the presynaptic terminals of sympathetic
neurons67. The alpha-2 receptor binds to the inhibitory Gi-protein; the stimulation of this
receptor decreases neurotransmitter release from sympathetic neurons, resulting in a
reduction in the overall level of sympathetic neurotransmission.
Despite the variety of pharmacologic treatment options available and their
widespread use, there still remains a strong need to develop additional therapies69. While a
general consensus exists for the efficacy of stimulants, a recent systematic review of
methylphenidate concluded that the evidence supporting its use is of very low-quality, and
more caution should be exercised in its use70. However, the benefits that do result from
stimulant use do not persist after discontinuation and patients with ADHD still suffer from
adverse long-term outcomes such as poor academic performance, drug addiction, and
criminal behavior to a much greater degree than non-ADHD subjects despite optimal
therapy71. Despite their tolerability in a majority of ADHD patients, the side effect profile
of stimulants (anxiety, irritability, insomnia, gastrointestinal distress, loss of appetite, and
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growth suppression) still precludes their use in a significant number of patients due to the
widespread need for their use. An additional safety concern of stimulants are their longterm effects, for which there is a paucity of research in humans. However, two recent
studies have shown altered cerebral blood flow responses after discontinuation of stimulant
use72 and reduced GABA levels in the pre-frontal cortex of ADHD patients who were
treated with stimulants at a young age73. Drug treatments also suffer from further underutilization due to parents’ concerns about their safety and preference for the use of nondrug treatments69. Finally, the widespread use of stimulants has also led to their misuse and
abuse for non-medical purposes, which may be obviated by a greater availability of other
effective treatments for ADHD.
An alternative treatment strategy for ADHD attracting wide interest is the targeting
of neuropsychological functioning, such as executive function impairments. Russell A.
Barkley proposed an executive function theory for ADHD in 1997, which states that an
impairment in the core executive function inhibition is the central causative factor in the
development of ADHD7. Since the hyperactive behavior of children with ADHD reflects a
lack of behavioral inhibition and the use of inhibition keeps attentional resources available
for the use of other executive functions, Barkley reasoned that a deficit in inhibition leads
to a cascade of impairments in other executive functions culminating in the characteristic
behavior of ADHD.
As discussed in Chapter 2, computerized training programs (including video
games) have drawn interest as a tool to train executive function deficits. Our lab is currently
conducting a pilot study of the online game Minecraft as a therapeutic video game (TVG)
to train executive function deficits in children with ADHD (Chapter 3). The effects of the
TVG intervention in combination with stimulants is being investigated to develop a
combination therapy that can address both the dopaminergic dysfunction and executive
function deficits in ADHD. Although the results of this study will be used to guide the
clinical development process, additional guidance for the optimization of the executive
function training activities will be provided by the computational model of executive
functions currently under development. This model is using ANNs to complete virtual tasks
that resemble the tasks that subjects with ADHD complete in the Minecraft world, and the
schedule of virtual tasks that result in maximum improvements in ANN function will
determine the selection of training regimens in future clinical studies.
An orphan drug indication for a drug/device combination of stimulants with the
therapeutic video game will be pursued for the treatment of ADHD-like symptoms in
Fragile X Syndrome (FXS)74. FXS is a rare genetic disorder and is the most common form
of inheritable mental retardation. Most commonly, FXS is caused by an excess quantity of
CGG-nucleotide repeats (>200) in the 5’-untranslated region of the fragile X mental
retardation 1 (FMR1) gene located on the X-chromosome. The expanded set of CGGnucleotide repeats leads to hypermethylation and silencing of the FMR1 gene, and
decreased production of the fragile X mental retardation 1 protein (FMRP).
The estimated prevalence of FXS is 1 in 4,00075, which qualifies this disorder for
the FDA’s Orphan Drug Designation Program that promotes accelerated drug development
for rare diseases76. ADHD symptoms are present in 80% of FXS patients, which can be
treated with stimulants and alpha-2 adrenergic agonists77-78. However, stimulants show
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efficacy in approximately 60% of FXS patient79, so drug therapy could potentially be
improved by the combination of stimulants with a therapeutic video game.
This intervention will utilize a novel personalized medicine approach where an
individualized treatment regimen consisting of an initial stimulant dose recommendation
and schedule of therapeutic video game activities will be determined from the initial
ADHD assessment results of new patients. We hypothesize that the training of ANNs can
serve as a computational model for the adaptations that biological neural networks undergo
in response to practicing of activities requiring the use of executive functions. In the model,
a set of ANNs will first be trained to resemble the pattern of executive function deficits
reflected in a new patient’s assessment responses. A large set of virtual tasks resembling
the therapeutic video game activities will be tested in the model, and the set of virtual tasks
that produces the maximum improvements in the ANNs of the virtual “subject” will predict
the analogous set of therapeutic video game tasks most beneficial for the human patient. A
future clinical study will test this hypothesis by including an experimental group with a
personalized executive function activity training schedule guided by the computational
model that will be compared with a control group completing an executive function activity
training intervention that is not guided by the computational model.
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CHAPTER 2. ADHD, PHARMACEUTICALS, AND VIDEO GAMES
2.1

Attention Deficit Hyperactivity Disorder

Diagnosis rates of ADHD in children range from 3-11% compared to 4% in
adults80-82. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5
million children were being treated with therapeutics as reported by their parents81.
Stimulant medications such as amphetamines and methylphenidate are currently the firstline treatment for ADHD66, although there are significant problems associated with their
use. They are often misused, abused, and diverted for nonmedical purposes. Stimulant use
is associated with, and, in many cases, limited by, side effects such as insomnia,
gastrointestinal distress, irritability, loss of appetite, and growth suppression66. Parents also
have poor perceptions of their safety69,85-86, and thus they remain underutilized as a
treatment option in children69,85-86. Although these medications are effective in controlling
symptoms in the short term in many patients, their efficacy does not persist after
discontinuation71, many patients may experience only a partial response or no response at
all87-88, and, even with treatment, children with ADHD still suffer from greater rates of
adverse long-term outcomes such as drug abuse and criminal behavior than healthy
children71.
2.2

Pharmacotherapy

Pharmaceutical therapy with stimulants is the most effective monotherapy for most
patients with ADHD, with the exception of the very young89. The advantages of combining
pharmaceutical therapy with behavioral therapy include lower cost, as personnel time with
patients is reduced, and reduced doses of pharmaceuticals (50-75%)90. Additionally, the
benefits of behavior therapy are more likely to carry forward once treatment has stopped90.
Behavior therapy for ADHD patients includes repetitively reducing negative behaviors
with consequences and increasing positive behaviors with rewards89. However, behavior
therapy is not widely available to all patients, and its benefits are limited to the targeted
behaviors only71.
2.3

Video Games

A potential alternative approach to address these issues is to improve the cognitive
processes that underlie the observed symptoms71. One potential intervention target to do
so is executive function, which is a set of top-down mental processes that regulate
distracting influences and automatic, unproductive behaviors to enable self-control1.
Training of the core executive function working memory has previously been shown to
increase cortical D1 receptor density91. As dopaminergic function is compromised in
ADHD92, these alterations could provide additional benefits in improving the function of
patients with ADHD. To this end, computer-based programs with repeated cognitive
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exercises without video game elements have been used as a treatment intervention in
ADHD93. However, it is thought that delivery of these interventions in a video game format
can help improve their effects by promoting a state of optimal cognitive performance and
increasing the participant’s focus and motivation to complete them93. Indeed, children with
ADHD have shown reduced impairments in inhibition (but not working memory) while
playing video games94, and the addition of video game elements to executive function
training tasks have resulted in improvement of working memory95-96 as well as improved
working memory performance over time96.
In addition, training methods used to enhance learning have traditionally shown
effects only in the specific areas targeted by the training97. However, healthy action video
game players have outperformed non-players in a broad variety of cognitive performance
measures, including some executive functions such as flexibility and top-down attention,
suggesting their potential usefulness as a cognitive training tool97. Notably, improvements
in these areas have been seen in randomized, controlled trials of non-players trained with
either an action video game or a non-action video game (as an active control group) in the
action video game group only, suggesting that action video games have a causative role on
this improved performance97. Furthermore, video gaming may be able to increase
motivation and one’s ability to learn98. This effect is thought to be mediated by games
producing increased striatal dopamine levels99-100 that enhance long-term potentiation of
neural connections in the striatum101. The potential of using a video game as a therapeutic
tool was further evidenced in a recent article in the journal Nature that described a video
game training multitasking ability that was capable of improving measures of the
neurological functions that underlie cognitive control in elderly subjects102. Thus, by using
a video-game based cognitive training intervention as part of a drug/device combination
with stimulants, it could be possible to increase the efficacy of currently available
treatments and/or reduce the dose of stimulants needed to control symptoms.
However, video game play has also been associated with several adverse effects.
Like pharmaceuticals, the effect seen seems to be related to the amount and style of video
games to which humans are exposed. First-person shooter games with violence have been
associated with anxiety and fear103. However, these associations have been found in
subjects with excessive video game use or internet gaming addiction,104-112 (but see Ref.
113) and it is thought that the excessive gaming could be used as a form of escape from
negative emotions rather than a causative factor for them107-108,111 (but see Ref. 109). The
negative outcomes of video game play include obesity, aggressiveness, antisocial behavior,
and addiction103. Although video games could potentially be advantageous as a learning
aid, increased time spent playing video games has been associated with worse academic
performance114. Despite these concerns, there have not been any significant safety concerns
reported in studies using video games for executive function training. Thus, we suspect
that video game play using a schedule similar to the training interventions that have
resulted in improved executive function will still have a favorable safety profile compared
to pharmaceutical treatments.
Recognizing the therapeutic potential of video games, the FDA has issued a
guidance for therapeutic video app developers. Pfizer and Shire Pharmaceuticals are
funding research in video games, and companies like CogCubed and Akili are developing
video games for approval as FDA-regulated devices. Although drug companies are
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currently seeking prescription video games, they must eventually move toward drug/device
combinations to increase efficacy.
Most studies investigating executive function training in children with ADHD have
targeting single executive function only, mostly working memory. Visuospatial working
memory is considered the most important neuropsychological deficit in children with
ADHD115 and training of working memory has been shown to alter cortical dopamine D1
receptor density91. A recent meta-analysis concluded that the use of cognitive training
interventions targeting working memory or attention alone have resulted in substantial
improvement in these executive functions, with some studies also showing improvements
in parent ratings of ADHD symptoms88. The improvements in working memory have been
shown to persist at 6 months116-117 and 8 months118 after completion of training. However,
far transfer effects to functional areas beyond the targeted executive functions (such as
improvements in academic measures) and teacher ratings of ADHD symptoms have
remained largely unaffected119-121. These inconsistencies could potentially be due to
practice effects resulting from repeated assessments affecting the executive function
measures and insufficient blinding procedures affecting parents’ ratings88.
The scope of research involving cognitive training interventions targeting multiple
executive functions is more limited than for those targeting a single executive function.
However, studies investigating interventions targeting multiple executive functions have
shown a greater magnitude in improvement of ADHD symptoms assessed by parents
compared to those targeting a single executive function88,115,122-125. Although these
improved effects could be due to an increased duration of training, it is possible that
training strategies targeting a broader set of executive functions may be required to
effectively address both the full spectrum of neuropsychological deficits present in ADHD
as well as the inter-individual variation of deficits among children with ADHD88.
With regard to ADHD symptom assessments by blinded raters, two recent studies
investigating an intervention with added video game elements to simultaneously train
multiple executive functions showed effects in teacher-rated outcomes. One intervention
training working memory, inhibition, and flexibility was able to produce moderate-to-large
improvements in ADHD symptoms ratings by teachers, but these effects were also obtained
with the placebo intervention, suggesting that the improvements were due to general
features of the intervention not related to the executive function training itself98. Another
intervention training time management, organization/planning, and cooperation resulted in
small-to-moderate improvements of parent-reported daily functioning in the areas of
working memory, time management, and responsibility126. Improvements in time
management were also reported by teachers in this study, suggesting that training
interventions targeting skills that are directly applicable in daily life could potentially
improve far transfer effects across multiple settings126.
Therefore, there is still a need to further explore the potential of using video gaming
interventions to train multiple executive functions, including those that are directly utilized
in daily life, as a treatment for ADHD. Our laboratory is currently conducting a pilot
clinical study investigating the use of the popular online game known as Minecraft in
combination with stimulant medications in subjects with ADHD. Minecraft is an online
video game containing a “virtual land where users can create their own worlds and
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experiences, using building blocks, resources discovered on the site and their own
creativity” that requires its users to apply problem solving, planning, and organizational
skills for creative building and exploration127. It has many levels of difficulty, which allows
for adaptation to users with a wide range of cognitive abilities as well as potential for
incremental progressions in difficulty as the user’s performance improves. Minecraft is
widely available across a variety of commonly used devices, its recommended age range
and content is appropriate for children, and its online world allows considerable flexibility
for designing a variety of activities that challenge executive functions. In Survival Mode,
Minecraft becomes an action game that should carry action game benefits.
One possible mechanism of action associated with the effects of Minecraft on
ADHD is the opportunity for reinforcement of positive behavior and punishment for
negative behaviors provided by Minecraft. Minecraft is an online medium with several
built-in components similar to behavior therapy exercises but enjoyable so that children
want to play. High performance in several major executive functions noted to be lacking
in ADHD children is positively reinforced by gameplay, in that success yields completion
of a specific task, acquisition of a rare in-game item, or even character survival in a given
situation. Furthermore, Minecraft allows players to re-attempt failed challenges as
characters re-spawn after death, though with certain disadvantages. This both gives players
the impetus to improve in those executive functions (to prevent character death or hassle)
and the ability to continue improving.
In contrast to the behavioral training components of Minecraft, the training of
executive function is expected to yield more generalizable benefits across multiple
environments, because executive function processes underlie all cognitive processes while
training to modify behaviors can only affect the specific behaviors targeted69. In order to
direct the practice of executive functions, during this trial players are required to work from
an activity list with additional reinforcement for practicing behavior therapy type activities.
The activity list includes two tasks of increasing difficulty for each of the following
executive function skills: planning, time management, self-regulation, sustained attention,
organization, response inhibition, working memory, goal-directed persistence, flexibility,
and metacognition. A self-assessment component of the trial provides an additional
opportunity to encourage subjects to develop metacognition. Thus, the training activities
address both the underlying core executive functions (working memory, inhibition, and
cognitive flexibility), as well as executive function skills utilized in school and work
settings (planning, time management, self-regulation, sustained attention, organization,
goal-directed persistence, and metacognition).
The primary objective of this trial is to derive a functional relationship between
NICHQ scores (an assessment that measures ADHD symptoms as well as the patient’s
function in everyday life), game aspects of Minecraft, and executive function. All patients
in this study are required to be on stimulant drugs, so the effects of varying stimulant doses
on the changes in executive function can also be explored. The development of this
functional relationship could ultimately enable a personalized medicine approach to the
treatment of ADHD by identifying the executive functions where an individual is most
deficient and predicting the stimulant drug dosage and nature and schedule of the Minecraft
activities that would be most effective for treating these deficits. This strategy could
potentially improve the efficacy of treatment by targeting each patient’s unique deficits, as
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well as reduce the time to achieve optimal treatment effects by using artificial neural
networks to simulate the patients’ Minecraft therapy (Neural networks can be programmed
to perform tasks in Minecraft faster than humans).
The executive function deficits are assessed by a patient’s pattern of responses on
the NICHQ assessment, and the nature and schedule of the Minecraft activities used to
correct these deficits predicted by a computational model utilizing artificial neural
networks (ANNs). Artificial neural networks are a computational technique inspired by the
structure and function of biological neural networks and categorized under the headings of
artificial intelligence and machine learning. Due to their similarity to biological neural
structures, it is possible that the learning processes that occur during the training of an ANN
could be used to simulate the learning processes that occur in human subjects from the
completion of cognitively demanding tasks. An abbreviated “NICHQ” which assesses
behavior that can be appropriately observed in the context of the computational model will
be used to measure changes of executive functioning within the model that result from the
application of computational tasks that are similar to the Minecraft activities that the human
subjects perform. Separate models will be developed with ANNs that show poor
performance (ADHD-ANNs) and relatively good performance (control-ANNs) on these
tasks. Modifications of these tasks will also be tested in this manner to determine how
optimal performance improvements in the ADHD-ANNs can be produced. Finally, these
modified tasks will be tested in a future clinical study to determine the external validity of
the model.
The structure of these computational models will be based on three of the core
executive functions: inhibitory control, working memory, and cognitive flexibility1.
Inhibitory control refers to the ability to suppress the influence of internal or external forces
that distract one from accomplishing a goal.3-4 Inhibitory control works closely together
with working memory1, which is the ability to hold information in mind after it is no longer
perceptually present and effectively manipulate it as desired2. For example, using working
memory to focus attention on accomplishing a goal helps to remove attention from
distracting impulses. Similarly, using inhibitory control to focus attention away from
distracting impulses supports the use of working memory by leaving more mental “working
space” available to be directed towards accomplishing a goal. Cognitive flexibility5
involves the ability to change perspectives, which requires the simultaneous use of both
inhibitory control and working memory, where inhibitory control is used to resist the
influence of one’s current perspective on their actions and working memory is used to hold
a new perspective in attention to change one’s actions accordingly1.
The first of the core executive functions, inhibitory control, is represented by an
“Impulsivity” function, the value of which will increase over time and result in the
activation of a distracting activity once its value increases above a given threshold. An
ANN will be able to modify the parameters of this Impulsivity function, and a repeatedly
executed training procedure will be implemented where the ANN will learn to modify these
parameters more effectively to prevent the distraction function from activating as training
proceeds.
Secondly, working memory will utilize this inhibitory control structure, but with
the inclusion of a “Goal Activation” function and a working memory mental space. This
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function will work similar to the Impulsivity function, but if its value crosses a given
threshold, then a goal activity function will be activated (as opposed to the distractor
activity function). The working memory mental space will be represented by immediate
computer memory, where function instructions (for either the goal or distracting activity)
and the values of their associated parameters can be efficiently accessed and manipulated
by the CPU. In this case, the implemented training procedure will be designed such that
the ANN will learn to simultaneously modify the parameters of both the Impulsivity and
the Goal Activation function to more effectively devote computational resources towards
the completion of the goal activity and consequently complete the appropriate task function
more efficiently.
Finally, cognitive flexibility will utilize the described interaction between
inhibitory control and working memory, but at a given time point, the conditions of the
task shall be changed such that activities other than the goal activity are to be performed
for a given time period. Eventually, the conditions will be switched back so that the goal
activity is to be completed once again, and this pattern will then be repeated in a cyclical
manner. When computational resources are to be focused on the goal activity, the training
of the ANN will involve diminishing the value of the Impulsivity function while increasing
the value of the Goal Activator function as described above. However, when the conditions
of the task change such that the goal activity is not to be pursued, the training of the ANN
will be altered to instead increase the value of the Impulsivity function while diminishing
the value of the Goal Activator function. An effectively trained ANN for cognitive
flexibility will be able to more rapidly perform these transitions, and devote computational
power towards the goal only when appropriate based on the given conditions.
2.4

Preliminary Feasibility Study

A preliminary study was conducted to determine the feasibility of performing a
basic simulation of a working memory deficit in an ANN. For this experiment, a
convolutional neural network (commonly used in image recognition applications) was
utilized to identify images of handwritten digits from the MNIST database. The MNIST
database is a publicly available database that contains a training set of 60,000 image files
and a test set of 10,000 image files of handwritten numbers, each with a label identifying
the correct number contained in the image8. The training set is used to present the ANNs
with examples from which to “learn” how to identify handwritten digits, while the test set
is used to measure the performance of the ANN in identify the digits after training has been
completed. This dataset is a commonly used tool to benchmark the performance of ANNs
in image recognition applications.
Wolfram Mathematica v11.1 was used for all calculations. Two ANNs of identical
convolutional structure, but differing in training procedures, were used in this study. The
first ANN was trained with the full MNIST training set and represented a “healthy” control
condition, while the second ANN was trained with a truncated form of the MNIST training
set and represented an experimental “ADHD” condition with a working memory
deficiency. The test set consisted of randomly selected images that were not included in
the training sets, and the performance of the trained ANNs was tested on six different test
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sets consisting of ten images each. The control ANN achieved 100% (SD 0%) correct
recognition of handwritten digits in sample images taken from the MNIST test set, while
the working memory-deficient ADHD-ANN achieved only 50% (SD 8.9%) correct
recognition of sample images taken from the MNIST test set (Figure 4).
Two examples of working memory (the ability to hold information in one’s
attention and manipulate it) include mentally relating information to derive a general
principle or to see relations between items or ideas, and incorporating new information into
one’s thinking or action plans1. The truncated training procedure represented a lack of
attention in the ADHD-ANN that led to its failure to derive the general principles and see
the proper relations between the images of handwritten digits and the number that they
contain. This deficiency was reflected in the ADHD-ANN’s inability to correctly identify
digits in the test set, which represented a failure to properly incorporate new information
into one’s thinking. Furthermore, since the ANNs were of identical structure, and differed
only in the training procedure, any differences in their performance would be interpreted
as being due to an environmental (rather than genetic) effect.
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Figure 4 - Working Memory Deficit Preliminary Study Results
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2.5

Conclusion

This work is an extensively simplified model of working memory, but future work
will focus on increasing its complexity. First, the modeling of working memory can be
improved by requiring the ANNs to make more complex manipulations of their input
images. For example, the ANNs can be trained to receive two image files with handwritten
numbers as an input, and then output the sum of these numbers. Alternatively, they could
be presented with image files containing handwritten words as inputs, and trained to output
these words spelled backwards.
Next, an additional task will be included (distractor activity) to model the
interaction of working memory plus inhibition, as well as cognitive flexibility. This task
will be a similar simple image identification task at first, such as identifying objects
contained in photographs, rather than handwritten numbers. To model the interaction of
working memory with inhibition, these models will first include the Impulsivity function
discussed earlier that is promoting the second distractor activity task. Then, to model
cognitive flexibility the ANNs will be required to switch their focus between the goal &
distractor functions at a given time interval. Finally, the complexity of the model will be
increased by using multiple ANNs in larger algorithms to model the more complex
executive function skills, such as planning or time management.
The use of this variety of ANN as a working memory model is not ideal from a
neurobiological perspective since working memory function has been linked to dorsolateral
prefrontal cortex activity4, which possesses a distinct structure and connectivity pattern
from the visual cortex. Despite the structural dissimilarities of CNNs with the prefrontal
cortex, working memory also relies on the cerebellum128 where supervised learning
processes are active129, and therefore CNNs may nonetheless be useful for modeling
adaptations of working memory function even if they are not capable of accurately
representing working memory function itself.
It will likely not be possible to capture the full complexity of executive function
processes with this approach. Nevertheless, it could be possible to develop this model to
the extent that it would provide some degree of utility for gaining insights into how
modifications of training tasks can affect performance of their targeted executive functions.
This utilization of ANNs to optimize a therapeutic intervention in the drug development
process would be a novel application that could result in considerable savings in time and
resources over the trial-and-error process for optimizing therapy that is now the standard
approach.
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CHAPTER 3. A PILOT STUDY OF A DEVICE AND DRUG THERAPY FOR ADHD
3.1
3.1.1

Introduction & Background
Background Information

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by difficulty paying attention, impulsivity, and hyperactivity. The medical
community has been largely unable to standardize an accepted definition of ADHD as
indicated by the medical community′s differing definitions according to Diagnostic and
Statistical Manual of Mental Disorders, 5th edition (DSM-5)130 and the International
Classification of Mental and Behavioural Disorders 10th revision (ICD-10)131. ICD-10
refers to disorders in this area as hyperkinetic disorders rather than attention deficit and
relies upon hyperactivity to distinguish ADHD from other disorders. The DSM-5 separates
patient phenotypes into three differing presentations: predominantly inattentive-type,
predominantly hyperactive-impulsive type, and combined inattentive hyperactiveimpulsive. Diagnosis of ADHD is predominantly based upon patient, teacher and parent
responses to standardized questionnaires containing questions based on a list of criteria for
diagnosing ADHD. People with ADHD are expected to have experienced at least six
symptoms of inattention (predominantly inattentive-type), or hyperactivity (predominantly
hyperactive-impulsive type), or both (combined) within the six months previous to the time
of the assessment.
In this study, we will use specially designed training activities performed within
the environment of the popular computer game Minecraft to determine if they affect
executive function, working memory, and restraint in patients diagnosed with ADHD.
Various cognitive training interventions are currently under investigation for their effects
on improving deficits in executive function in ADHD, and the addition of gaming elements
to the cognitive training may help improve outcomes (for review, see Ref 93 P. 5-9). For
example, utilization of a video game format to train biofeedback skills (reduction of heart
rate through slowed breathing) in children with ADHD resulted in improved scores on the
ADHD Questionnaire and the Strengths and Difficulties Questionnaire132. Gamification of
the Conners Continuous Performance Test II, used to measure sustained attention, resulted
in significant improvements in performance compared to the regular test in children with
ADHD133. The addition of gaming elements to standardized working memory training
tasks resulted in significantly improved motivation, training performance, and working
memory of children with ADHD95 and the use of a gaming task also normalized task
persistence in ADHD children in a visuospatial working memory task96. Finally, a multiple
domain executive function training game resulted in improvements in the specific domains
trained (inhibition, visuospatial short-term memory, and visuospatial working memory) in
children with ADHD, although no benefits were seen in overall behavior ratings98.
3.1.2

Rationale

3.1.2.1 Rationale for use of stimulant-type medications to treat ADHD

Amphetamines are non-catecholamine sympathomimetic amines with CNS
stimulant activity. The mode of therapeutic action in ADHD is not known, but
amphetamines increase extracellular dopamine and norepinephrine. These alterations in
extracellular neurotransmitters are a result of amphetamine's inhibition of the Dopamine
Transporter (DAT), Norepinephrine Transporter (NET), Vesicular Monoamine
Transporter-2 (VMAT- 2), and Monoamine Oxidase (MAO).
DAT and NET are located in the presynaptic terminal cell membrane, where they
function to clear dopamine and norepinephrine, respectively, from the synaptic cleft into
the presynaptic neuron. This clearance is necessary to end the response of the postsynaptic
neuron and recycle the neurotransmitters in the presynaptic neuron for subsequent
repackaging and release. Thus, competitive inhibition of DAT by amphetamine prolongs
the presence of dopamine in the synapse, which results in a greater degree of dopamine
signaling to the postsynaptic cell. In addition to competitive inhibition of DAT function,
amphetamine can reverse the direction in which dopamine is transported. This effect can
further increase synaptic dopamine levels beyond the level resulting from transport
inhibition alone. Although NET primarily uses norepinephrine as a substrate, it is also
capable of transporting dopamine and its inhibition can increase synaptic dopamine
levels134.
While DAT and NET are located in the presynaptic cell membrane, VMAT2 and
MAO are located within the presynaptic nerve terminal. VMAT2 is responsible for
transporting monoamine neurotransmitters into vesicles within the nerve terminal, after
which they can be released into the synaptic cleft. When VMAT2 is inhibited by
amphetamine, cytosolic dopamine levels will increase. The increased cytosolic dopamine
can then be acted on by the "reversed" DAT and transported into the synaptic cleft.
However, while in the cytosol, dopamine is also susceptible to oxidative degradation by
MAO. By inhibiting MAO function, amphetamine prevents this degradation and leaves
increased cytosolic dopamine available for transport into the synaptic cleft67. In contrast,
methylphenidate inhibits DAT and NET and has weaker inhibition of MAO than
amphetamine67. Thus, methylphenidate increases extracellular dopamine levels by
blocking its reuptake only, rather than also increasing its release as amphetamine does135.
3.1.2.2 Rationale for use of Minecraft as add-on therapy to stimulant type ADHD
medications
Diagnosis rates of ADHD in children range from 5-11% compared to 2.5% in
adults
. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5
million children were being treated with therapeutics as reported by their parents81. One of
the issues with continued reliance upon therapeutics to treat ADHD is that increased
availability tends to increase nonmedical use of amphetamine-type ADHD drugs by
adolescents and young adults. In addition, parents prefer non-drug treatment options for
ADHD83, and thus medical treatments for ADHD remain underutilized85. Finally, the
beneficial effects of currently available drug and behavioral therapies do not persist after
discontinuation71,138, thus making alternative treatments with benefits that continue longterm highly desirable.
80-82

Some new companies make video games designed to treat ADHD, and FDA has
issued a guidance for therapeutic game designers. Lexington is becoming a hotbed of
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videogame development137-138. Pfizer and Shire Pharmaceuticals are funding research in
videogames. Drug companies will head toward drug/device combinations, even though
they currently seek prescription video games. Companies like CogCubed and Akili are
developing videogames for approval as FDA regulated devices, but not drug device
combinations. There is some evidence of efficacy of games, but the efficacy could be
improved. The ultimate goal is to increase overall treatment efficacy and create the first
FDA-approved device/drug combination for ADHD treatment.
To that end, this clinical trial will be conducted as an exploratory study to
investigate the functional relationship between NICHQ scores, game aspects of Minecraft,
and executive function. Two study groups will be included: a videogame group (ADHD
drug regimen + Minecraft a minimum of 30 minutes per day, 5 times per week x 4 weeks)
and a control group (ADHD drug regimen only x 4 weeks). By using a no Minecraft control
group who will continue their usual ADHD medication regimen, we expect to be able to
determine the effect on executive function from adding Minecraft to the usual standard of
care for ADHD. (All subjects enrolled in the study will be free to play any video games or
computer games that they want to play during the course of the study. However, the
Minecraft group will be the only group of subjects playing in the private Minecraft Realm
and doing the activities described there.) Furthermore, subjects in the control group will be
taking varying doses of stimulant medications as well as different types of stimulant
medications prior to enrolling in the study. This will allow for easier recruitment and, more
importantly, allow for additional data to be collected. A dose response effect across dose
parameters will be examined, and the introduced variance will be managed with factor
analysis139. However, one potential problem in this study design is the effects of other
medications used to treat ADHD (such as atypical antipsychotics or alpha-2 receptor
agonists) that may have negative effects on cognitive function, and therefore confound the
results. We expect that such effects will be negated by requiring that the study subjects are
being treated with a stimulant medication, which would counteract the negative effects of
these medications on cognitive function.
Previous studies which found effects of gaming interventions on executive function
have used study durations ranging from 2-16 weeks, with 2-5 training sessions per week93.
However, a less intense schedule of 5 x 30 minute (minimum) game sessions per week for
4 weeks was chosen for this study because of concerns related to lowered compliance to
study procedures. These concerns are due to the study’s taking place during the school
year, when increased time demands for the study subjects could limit adherence to a more
intensive intervention schedule.
Our hypothesis is that subjects in the videogame group (usual ADHD drug +
Minecraft) will show improvements in NICHQ scores and executive function at the end of
the 4 week game playing period compared to the control group.
Pharmaceutical therapy is the most effective monotherapy for most patients with
ADHD, with the exception of the very young89. The advantages of a combining
pharmaceutical therapy with behavioral therapy include lower cost, as personnel time with
patients is reduced, and reduced doses of pharmaceutics (50-75%)90. Additionally, the
benefits of behavior therapy are more likely to carry forward once treatment has stopped90.
Behavior therapy for ADHD patients includes repetitively reducing negative behaviors
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with consequences and increasing positive behaviors with rewards89. One possible
mechanism of action associated with the effects of Minecraft on ADHD is the opportunity
for reinforcement of positive behavior and punishment for negative behaviors provided by
Minecraft. Minecraft is an online medium with several built-in components similar to
behavior therapy exercises but enjoyable so that children are likely to want to play. High
performance in several major executive functions noted to be lacking in autistic children is
positively reinforced by gameplay, in that success yields completion of a specific task,
acquisition of a rare in-game item, or even character survival in a given situation.
Furthermore, Minecraft allows players to re-attempt failed challenges as characters respawn after death, though with certain disadvantages. This both gives players the impetus
to improve in those executive functions (to prevent character death or hassle) and the ability
to continue improving.
Application of executive functions in gameplay is exemplified in the following:
1) Executive Functions Exemplified in Construction - A great deal of time and
focus are required to acquire the necessary resources and build a desired project,
particularly in Survival mode (a mode of gameplay which requires players to
harvest resources while harassed by cartoon monsters); a great amount of time and
self-direction are required to build an ideal structure in Creative mode as well (a
mode of gameplay in which players have free, unlimited access to all resources,
unlimited mobility, and no danger of character death). The construction of complex
structures requires inhibition as players must work exclusively on one project to
complete it in a timely fashion, working memory as players must mentally construct
the project in their minds in order to place building blocks on the proper squares of
the game grid, planning as players choose how much of the resources they wish to
acquire and design their structures, and self-monitoring as players balance their
time and the amount of risk associated with the acquisition of resources.
2) Executive Function Exemplified in Mobility - Manual dexterity is required for
proper placement of blocks, navigation of obstacles, and combat with cartoon
monsters. All of these can be difficult, and the failure to execute these maneuvers
correctly results in character death (and loss of experience and items) and/or in the
frustration of traveling back to the location, often over difficult terrain.
3) Executive Function Exemplified in Fluidity - Maintaining and changing mental
set and emotional regulation is applicable to overcoming challenges presented in
survival mode in particular, though challenges also arise in the building process in
any mode, and players often have to modify their strategies in order to succeed.
4) Executive Function Exemplified in General Gameplay - Focus and concentration
skills are practiced as players must monitor their health and surroundings in the
game to stay alive. Due to the fact that Minecraft is borderless, subjects can become
lost if attention is not paid to their surroundings. While other games may also
require monitoring of health, there is an element of required organizational skills
that may be missing in other video games popular with this demographic. While
subjects will likely have an exhaustive inventory of general supplies after having
played for awhile, survival may mean the ability to find needed supplies quickly
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and acquisition of specialized resources is still a lengthy and sometimes difficult
process (when play is conducted in Survival mode).
In contrast to the behavioral training components of Minecraft, the training of
executive function is expected to yield more generalizable benefits across multiple
environments, because executive function processes underlie all cognitive processes while
training to modify behaviors can only affect the specific behaviors targeted69. Moreover,
training of working memory has previously been shown to increase cortical D1 receptor
density91. As dopaminergic function is compromised in ADHD92, these alterations could
provide additional benefits in improving the function of patients with ADHD. In order to
direct the practice of these executive functions, during this trial players will be required to
work from an activity list with additional reinforcement for practicing behavior therapy
type activities. A self-assessment component of the trial will encourage subjects to develop
self-cognition, or metacognition.
In addition to its effects on behavior and executive function, Minecraft could
beneficially affect neurological functions underlying cognitive control. A previous study
assessing the effects of a therapeutic video game designed to train multitasking ability in
elderly subjects found that improvements in multitasking were associated with increases in
midline frontal theta power and long-range theta coherence between the frontal and
posterior brain regions as determined by two electroencephalography methods used to
assess cognitive control. These improvements persisted for six months following the
completion of training and reached a level comparable to that of younger adults102.
Furthermore, utilizing cognitive training activities in a gaming format is suggested
to increase motivation and one’s ability to learn98. This effect is thought to be mediated by
games producing increased striatal dopamine levels99-100 that enhance long-term
potentiation of neural connections in the striatum101,140.
3.1.3

Potential Risks and Benefits

3.1.3.1 Known Potential Risks of Video Games, Specifically Minecraft
The immediate risks of this study appear to be few. Although there is little research
on the effect of Minecraft in humans, there is considerable research on the effects of other
video games. Like pharmaceuticals, the effect seen seems to be often related to the amount
and style of video games to which humans are exposed. One person shooter games with
violence are associated with anxiety141. The negative outcomes of video play include
obesity142, aggressiveness143, and addiction144. The risk of obesity is complicated by some
studies that suggest high school students who exceeded the recommended screen time (TV
and computers) were also more likely to consume fast food and sugary drinks and less
likely to consume fruits and vegetables145. Additional potential risk might include eye
strain146, repetitive motion injuries147, seizures148, and vertigo/motion sickness149.
Diagnosis rates of ADHD in children range from 5-11% compared to 2.5% in
adults
. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5
million children were being treated with therapeutics as reported by their parents81.
Unfortunately, increased availability of stimulants tends to increase nonmedical use of
amphetamine-type ADHD drugs by adolescents and young adults. An estimated 97% of
80-82
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adolescents play video games150. On average, American children play video games at least
one hour per day151. Additional nonpharmaceutical therapies are needed for ADHD
because stimulant diversion is associated with increased availability of amphetamines. The
prevalence of ADHD along with the total amount of time American children spend playing
video games would provide a rationale for the study of both.
The video game chosen, Minecraft, is considered to be nonviolent. One of the only
violent aspects is cartoon skeletons that have the ability to shoot arrows. Thus, care has
been taken to select a nonviolent game. Secondly, time spent playing Minecraft was limited
to 30 minutes/day, far less than the normal amount of time most American children spend
playing video games. Risks have also been minimized with purchase of private Minecraft
Realms for the participants. Children playing Minecraft during the trial will only interact
with investigators and other subjects while playing and their play will be monitored
periodically by investigators to ensure appropriate play by all.
3.1.3.2 Known Potential Risks of Video Games with CNS Stimulant Treatment
Little is known about potential risks of videogame play with a background of CNS
stimulant treatment. Sudden death has been reported in association with CNS stimulant
treatment alone at usual doses in children and adolescents with structural cardiac
abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious
cardiac problems that may predispose increased vulnerability to the sympathomimetic
effects of a stimulant drug.
Administration of stimulants may exacerbate symptoms of behavior disturbance
and thought disorder in patients with pre-existing psychotic disorder. Particular care should
be taken in using stimulants to treat ADHD patients with comorbid bipolar disorder
because of concern for possible induction of mixed/manic episode in such patients.
Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional
thinking, or mania in children and adolescents without prior history of psychotic illness or
mania can be caused by stimulants at usual doses.
Other adverse effects of amphetamines include growth suppression, loss of
appetite, weight loss, stomach ache, insomnia, headache, rebound symptoms, and
irritability/jitteriness66.
3.1.3.3 Known Potential Benefits of Video Games
Action video games are associated with increased multiple tracking tasks
(improved attention)152, increased basic cognitive skills such as tracking objects moving at
greater speeds, better ability to detect changes to objects stored in visual short-term
memory, to change tasks more rapidly, and mentally rotate objects more efficiently153.
3.2
3.2.1

Objectives and Purpose
Primary Objective

To derive a functional154 relationship between NICHQ scores, game aspects of
Minecraft, and executive function.
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3.2.2

Secondary Objectives

Using EDA and factor analysis, we will examine specific clinical symptoms of
ADHD, including deficits in inhibition, working memory, planning, self-monitoring,
verbal regulation, motor control, maintaining and changing mental set and emotional
regulation as revealed by the NICHQ questionnaire and other assessments, that are affected
by putative therapeutic features of the game Minecraft to determine which features to
enhance to increase effectiveness of the intervention.
3.3
3.3.1

Study Design and Endpoints
Description of the Study Design

This clinical trial will be conducted as an exploratory, randomized parallel open
label pilot study to investigate the functional relationship between NICHQ scores, game
aspects of Minecraft, and executive function in ADHD patients receiving stimulant type
medications as standard of care.
The study has two arms and is conducted at a single center using multiple
physicians. The study agent/intervention is the video game Minecraft. Subjects will be
randomized by sex and age to the video game group or the combination group. The two
study groups include a study group (ADHD drug regimen + Minecraft played for a
minimum of 30 minutes per day, 5 times per week for 4 weeks) and a control group (ADHD
drug regimen only followed for 4 weeks). There are no schedule changes, stratifications,
or dose escalations.
3.3.2

Study Endpoints

3.3.2.1 Primary Endpoint
The primary endpoint of this pilot study will be change in ADHD symptoms as
measured by the NICHQ questionnaire after 4 weeks of therapeutic gaming. No statistical
hypothesis is being tested. Post hoc exploratory data analysis (EDA) techniques will be
applied to compare drugs used and their doses along with game features to the NICHQ
results.
3.3.2.2 Secondary Endpoint
Using EDA and factor analysis, we will examine specific clinical symptoms of
ADHD, including deficits in inhibition, working memory, planning, self-monitoring,
verbal regulation, motor control, maintaining and changing mental set and emotional
regulation as revealed by the NICHQ questionnaire and other assessments, that are affected
by putative therapeutic features of the game Minecraft to determine which features to
enhance to increase effectiveness of the intervention.
3.3.2.3 Exploratory Endpoints
Not Applicable.
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3.4
3.4.1

Study Enrollment and Withdrawal
Participant Inclusion Criteria

In order to be eligible to participate in this study, an individual must meet all of the
following criteria:
1. Primary diagnosis of ADHD in accordance with DSM-5.
2. On a current regimen of a stimulant type ADHD medication, such as Vyvanse.
3. Sex: males and females.
4. Age: between 10 and 15 years of age.
5. Stated willingness to comply with all study procedures and availability for the
duration of the study, including adherence to medication and play regimen.
6. Are capable, as determined by the investigator, to perform the following:
a. complete the study log.
b. are able to comply with the required study visits.
7. Have given written informed assent along with parents/legal guardians to
participate in this study in accordance to local regulations before any trial related activities
(other than initial screening) are carried out.
8. Are Minecraft players and have access to a full version of PC/Mac (Java)
Minecraft, Xbox Minecraft, or pocket Minecraft version (Android, Kindle) that supports
play on Realms.
9. Subjects’ parents and subjects both currently have Google accounts and
electronic devices to access Google accounts online.
10. Must have an NICHQ Vanderbilt Assessment scored by parents and teacher(s)
within the last month, or get an assessment scored by parents and teacher(s) within one
week of enrollment and before beginning to play the video game if the subject is in the
video game arm).
11. At least one parent and the subject must be proficient in spoken and written
English.
.
3.4.2

Participant Exclusion Criteria
Any of the following would render a person ineligible to participate in the study:
1. Current or past history of substance abuse.

2. Patients who for whatever reason are deemed by the investigator inadequate for
participation in this trial (e.g., patients with incapacitating mental illness).

3. Have previously completed or withdrawn from this study after having signed the
informed consent/assent document.
4. Lack of proficiency in spoken and written English
3.4.3

Strategies for Recruitment and Retention

As the study is a pediatric study, the pediatric population is the only one being
studied. ADHD disproportionately affects children and therefore, children are the subjects
being recruited. Recruitment will include females and minority groups as appropriate. The
ADHD population is predominantly male, so our study population will reflect the patient
population. The medical investigators contacted for this trial have indicated they
predominantly treat Medicaid patients, thus lower economic status patients should also be
adequately represented.
Compensation ($100/subject) will be provided to children and parents in a 60/40
split to compensate for their playing time, travel time, and expenses to the site. Children
will be given $60 gift cards for participation and one parent/legal guardian will be paid $40
via check.
As the study duration is only 4 weeks, study retention is not likely to be a problem.
Additionally, study personnel will contact subjects periodically if subjects do not appear to
be logging on and playing Minecraft or if data is not being shared with researchers. Subjects
will be asked to unshare their data with us after the trial has been completed.
UK CCTS will be the only clinical site. Thirty-two patients (32) will be screened
in order to enroll 16 subjects (8 female 8 male), to ensure 12 complete the study. The study
will enroll 16 participants (8 female, 8 male) with a previous medically confirmed
diagnosis of ADHD at the CCTS in order to have at least 12 complete the study. All of the
16 subjects enrolled will currently be on a stimulant type ADHD drug regimen with active
prescriptions.
An i2b2 survey conducted in July 2016 identified 257 potential subjects which are
currently on a standard of care including a stimulant type ADHD drug. It is expected that
all investigators will go through their medical files and will review existing patient records
to screen these patients for inclusion and exclusion criteria. Similarly, additional study
candidates will be referred by other physicians or will respond to advertisements or web
announcements made by CCTS if recruitment falls short of goals.
3.4.4

Participant Withdrawal or Termination

3.4.4.1 Reasons for Withdrawal or Termination
Participants are free to withdraw from participation in the study at any time upon request.
An investigator may terminate participation in the study if:
Any clinical adverse event (AE), laboratory abnormality, or other medical
condition or situation occurs such that continued participation in the study would
not be in the best interest of the participant
The participant meets an exclusion criterion (either newly developed or not
previously recognized) that precludes further study participation.
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3.4.4.2 Handling of Participant Withdrawals or Termination
In case any participant drops-out from the study at any given point during the study
period, every effort will be made to contact the subject by phone, mail, and email to
investigate the reason for the subject stopping participation in the trial. Should a subject
decide to withdraw, all efforts will be made to complete and report the observations as
thoroughly as possible and collect study products (NICHQ assessments, Minecraft Realms,
self-assessments). Additional subjects initially screened but not enrolled may be added if
the investigators feel this is warranted.
3.4.5

Premature Termination or Suspension of Study

This study may be temporarily suspended or prematurely terminated if there is
sufficient reasonable cause. Written notification documenting the reason for study
suspension or termination will be provided by the suspending or terminating party to the
Investigator, funding agency, and regulatory authorities. If the study is prematurely
terminated or suspended, the PI will promptly inform the IRB and will provide the
reason(s) for the termination or suspension.
Circumstances that may warrant termination or suspension include, but are not limited to:
Determination of unexpected, significant, or unacceptable risk to participants
Demonstration of efficacy that would warrant stopping
Insufficient compliance to protocol requirements
Data that are not sufficiently complete and/or evaluable
Determination of futility
The study may resume once concerns about safety, protocol compliance, data quality are
addressed and satisfy the sponsor and IRB.
3.5
3.5.1

Study Agent
Study Agents(s) and Control Description

3.5.1.1 Acquisition
The study agent in this study is the video game Minecraft. The subjects will already
be Minecraft players and will already have Gmail accounts. The subjects will receive
instructions for Minecraft play via their Google Mail accounts. Study subjects will already
be on a regimen of prescription drugs as standard of care from their physicians.
3.5.1.2 Formulation, Appearance, Packaging and Labeling
The Minecraft game is available for download on the Internet and has no packaging,
labeling or appearance.
32

Minecraft Study participants in this protocol will already be on a regimen of various
FDA approved stimulant-type ADHD medication therapies in various doses. Those drugs
are standard of care agents and it is not practical to discuss the formulation, appearance,
packaging or labeling of all the different types of possible pharmaceuticals.
3.5.1.3 Product Storage and Stability
Minecraft can be stored on a hard drive or removable media (such as a USB
memory stick). Downloaded Realm worlds will be saved with a user’s single player worlds.
Downloaded worlds are accessible offline and are available for upload to another Realm
or world on your Realm.
3.5.1.4 Preparation
Subjects will be asked to play the desktop computer version of Minecraft.
3.5.1.5 Dosing and Administration
Subjects will be asked to play Minecraft for a minimum of 30 minutes per day five
times per week.
3.5.1.6 Route of Administration
Not applicable.
3.5.1.7 Starting Dose and Dose Escalation Schedule
Subjects will be asked to play Minecraft for a minimum of 30 minutes per day five
times per week. There will be no escalation.
Subjects will maintain their prescribed doses of ADHD medication that were
determined by their physician prior to enrollment in the study.
3.5.1.8 Dose Adjustments/Modifications/Delays
Not applicable.
3.5.1.9 Duration of Therapy
The videogame trial is scheduled to last for four weeks. Subjects will maintain
current standard of care during and after the trial.
3.5.1.10

Tracking of Dose

Subjects will log their own video game play on their existing online accounts.
Parents will track children’s medication compliance on their existing online
accounts. They will be asked to share the data periodically with investigators.
3.5.1.11

Device Specific Considerations

Not applicable.
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3.6
3.6.1

Study Procedures and Schedule
Study Procedures/Evaluations

3.6.1.1 Study Specific Procedures
Medical history will be obtained by interview by CCTS. Most recruited individuals
will be the patients of the initial medical investigators and the investigators will also have
their patients’ histories. Investigators will be added if recruitment falls short of goals.
Questions to be asked of subjects include:
1. Do you have any current medical problems or issues other than ADHD?
2. What illnesses have you been diagnosed with in the past? Age at diagnosis?
3. What surgeries have you had in the last five years?
4. How often do you normally play computer and video games? What hardware
platforms do you use (desktop, pad, phone, console?) How long is an average
session of playing on each? What video games have you previously played on each?
What are the dates you played these games (i.e., approximately when did you start,
and if you no longer play, when did you stop?)
Medicinal history will be obtained by interview. CCTS personnel will use this
information to ascertain whether subjects are eligible for enrollment as all participants are
required to be currently taking a stimulant type ADHD medication.
Questions will include:
1. What prescription medications are you taking for ADHD? What are the doses
and schedule?
2. What prescription medications are you taking for other indications? What are the
doses and schedule?
3. What OTC medications, or herbal supplements are you currently taking? What
are the doses? How often do you take them?
Physical examination will include height and weight at both exams.
Discussion Points:
1. No results will be shared with trial subjects.
2. Assessment of study agent adherence
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3. Administration of questionnaires or other instruments for subject-reported
outcomes, such as the NICHQ, self-assessment questions, parent reported study
compliance for medications, video gaming log, and completed activity list.
3.6.1.2 Standard of care study procedures
A Psychiatrist will serve as the medical director and a site PI. The PI as well as the
other physicians (Medical Investigators) are responsible for standard of care and NICHQ
assessments from parents and teachers.
Standard of care for children 6-11 years of age is FDA-approved medications for
ADHD and/or evidence based parent and or teacher-administered behavior therapy as
treatment, preferably both89. Stimulant based medication is strongly recommended.
Adolescents, aged 12-18, should be administered FDA-approved ADHD medication with
the patient’s accent. Behavior therapy may also be added to the prescription regimen. The
dose of the medication should be titrated to achieve the maximum benefit of the drug with
the fewest side effects.
3.6.2

Laboratory Procedures/Evaluations

3.6.2.1 Clinical Laboratory Evaluations
Not applicable.
3.6.2.2 Other Assays of Procedures
Not applicable.
3.6.2.3 Specimen Preparation, Handling, and Storage
Not applicable.
3.6.2.4 Specimen Shipments
Not applicable.
3.6.3

Study Schedule

3.6.3.1 Screening
This is a rolling enrollment trial. Enrollment is expected to be open for a maximum
of 62 days. Final visit will occur within 7 days of completing 42 days of video therapy.
Prescreening Visit (Day 0 to 60)
•

Obtain informed consent/assent of potential participant verified by
signature on written informed consent for screening form.

•

Review medical history
inclusion/exclusion criteria.

•

Review medications history
inclusion/exclusion criteria.

•

Review history of computer and video game play (which games, start date,
end date, minutes per day

to
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Prescreening Visit (Day 0 to 60, cont.)
•

Perform medical examinations needed to determine eligibility based on
inclusion/exclusion criteria.

•

Provide participants with instructions, such as, we will evaluate your tests
and contact you within 4 weeks to tell you whether you have been chosen
to participate in the study. Do not do anything regarding this trial until we
contact you. If you are chosen you should follow the instructions in the
subject instructions (hand potential subjects’ and parents a copy of these
instructions). Review important parts of the trial protocol in the instructions
including the difference in the trial groups, the IT requirements, and the data
to which the investigators will expect to be given access.

3.6.3.2 Enrollment/Baseline
Enrollment (Day 1-44)
● Ascertain that potential participants have NICHQ scores (no older than 1 month
old) from parents, collected on visit 1, and teachers, submitted by medical
investigators, before subjects can be enrolled in trial. After eligibility has been
determined, attempt to enroll eligible subjects, with priority given to 10-12 years
old, but open up to 15 year olds if 16 subjects are not available in the 10-12 yearold range, with randomization based upon age and sex. If for any reason the final
NICHQ assessments from teachers are not available, the study will simply treat
them as missing data. However, the initial assessment must be available for
enrollment. Enrollment will be conducted by electronic means ( telephone and/or
email).
● Contact eligible participants via phone to reconfirm current eligibility and
enrollment, provide groups assignment, and review study instructions, including
continuing with ADHD medication. If potential participants can not be reached
after 3 phone call or 2 emails, they will be excluded from the study and another
participant enrolled. Ask subjects to verbally confirm what their activities will be
during the trial to confirm their understanding. Gather Google emails addresses
from parents and children, if available. Determine which version of Minecraft the
subjects randomized to the Minecraft group will play (i.e. do subject wish to play
via a PC or a gaming console or mobile device) Details to discuss with participants:
See phone script. Remind subjects that study instructions will also be shared with
them via Google Drive.
● Schedule final study visits for participants who are enrolled in the study.
3.6.3.3 Follow-up
Not applicable.
3.6.3.4 Final Study Visit
Final Study Visit (Visit 2, Day 29-86, including + 7 day window to have final visit after
last completer of 28 days of video therapy)
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•

Record adverse events as reported by participant or observed by
investigator. Subjects will be told to report AEs to their physician.

•

Record weight and results of post- NICHQ questionnaire. The post study
NICHQ data will allow us to assess the primary endpoint, change in NICHQ
scores. The secondary endpoints can be assess through the electronic data
made available to the investigative team periodically by the subjects and
their parents throughout the study.

•

Record participant’s adherence to regimen.

•

Provide final instructions: Continue your standard of care routine from your
physician.

•

Inform patients and parents that data will not be available to them. Since
this is an exploratory study neither efficiency nor safety is being assessed.
Thus, it is unlikely to present any meaningful information to the subjects.
It will likely consist of only patterns and be used to guide further research.

3.6.3.5 Early Termination Visit
If an early termination visit occurs, all final study visit procedures should be
performed.
3.6.3.6 Unscheduled Visit
Since this trial is only 4 weeks long, it is doubtful that any unexpected visits will
occur. If an unscheduled visit should occur data concerning AEs will be documented.
3.6.4

Concomitant Medications, Treatments, and Procedures

All concomitant prescription medications taken during study participation will be
recorded on the case report forms (CRFs). For this protocol, a prescription medication is
defined as a medication that can be prescribed only by a properly authorized/licensed
clinician. Medications to be reported in the CRF are concomitant prescription medications,
over-the-counter medications and nonprescription medications.
3.6.4.1 Precautionary Medications, Treatments, and Procedures
Not applicable.
3.6.4.2 Prohibited Medications, Treatments, and Procedures
Not applicable.
3.6.4.3 Prophylactic Medications, Treatments, and Procedures
Not applicable.
3.6.4.4 Rescue Medications, Treatments, and Procedures
Not applicable.
3.6.4.5 Participant Access to Study Agent at Study Closure
Although Minecraft is commercially available to play for free the Minecraft Realms
used in this study will be closed and not available for additional play by participants.
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Table 1 - Schedule of Events in Therapeutic Video Games Pilot Study
Event

Visit 1 Screening

Registration

x

Schedule Visit (Terminal )

Enrollment

Final Visit

x

Informed Consent/Assent

x

Medical History

x

Demographics

x

Previous & Concomitant
Medication interview

x

x

Review
Inclusion/Exclusion criteria

x

x

Dispense questionnaire
tests (ADHD assessment)

x

x

Education materials-collect
questionnaires

x

x

Randomize participants
CRF enter and Transmit

x

x
x

x
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x

3.7
3.7.1

Assessment of Safety
Specification of Safety Parameters

3.7.1.1 Definition of Adverse Events (AE)
Adverse event means any untoward medical occurrence associated with the use of
an intervention in humans, whether or not considered intervention-related (21 CFR 312.32
(a)).
3.7.1.2 Definition of Serious Adverse Events (SAE)
An AE or suspected adverse reaction is considered "serious" if, in the view of either
the investigator or sponsor, it results in any of the following outcomes: death, a lifethreatening adverse event, inpatient hospitalization or prolongation of existing
hospitalization, a persistent or significant incapacity or substantial disruption of the ability
to conduct normal life functions, or a congenital anomaly/birth defect. Important medical
events that may not result in death, be life-threatening, or require hospitalization may be
considered serious when, based upon appropriate medical judgment, they may jeopardize
the patient or subject and may require medical or surgical intervention to prevent one of
the outcomes listed in this definition. Examples of such medical events include allergic
bronchospasm requiring intensive treatment in an emergency room or at home, blood
dyscrasias or convulsions that do not result in inpatient hospitalization, or the development
of drug dependency or drug abuse.
3.7.1.3 Definition of Unanticipated Problems (UP)
OHRP considers unanticipated problems involving risks to participants or others to
include, in general, any incident, experience, or outcome that meets all of the following
criteria:
Unexpected in terms of nature, severity, or frequency given (a) the research
procedures that are described in the protocol-related documents, such as the IRBapproved research protocol and informed consent document; and (b) the
characteristics of the participant population being studied;
Related or possibly related to participation in the research (“possibly related” means
there is a reasonable possibility that the incident, experience, or outcome may have
been caused by the procedures involved in the research); and
Suggests that the research places participants or others at a greater risk of harm
(including physical, psychological, economic, or social harm) than was previously
known or recognized.
This study will use the OHRP definition of UP.
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3.7.2

Classification of an Adverse Event

3.7.2.1 Severity of Event
All AEs will be assessed by the clinician using a protocol defined grading system.
For this trial, AEs related/not related will be those associated with playing the video game.
Stimulant related AE’s, which are standard of care, will be reported to Medwatch at
physician’s discretion. For AEs not included in the protocol defined grading system, the
following guidelines will be used to describe severity.
Mild – Events require minimal or no treatment and do not interfere with the
participant’s daily activities.
Moderate – Events result in a low level of inconvenience or concern with the
therapeutic measures. Moderate events may cause some interference with
functioning.
Severe – Events interrupt a participant’s usual daily activity and may require
systemic drug therapy or other treatment. Severe events are usually potentially lifethreatening or incapacitating.
3.7.2.2 Relationship to Study Agent
All AEs will have their relationship to study agent or study participation assessed
with a level of specificity appropriate to the study design.
The clinician’s assessment of an AE's relationship to study agent is part of the
documentation process, but it is not a factor in determining what is or is not reported in the
study. If there is any doubt as to whether a clinical observation is an AE, the event should
be reported. All AEs must have their relationship to study agent assessed. In a clinical trial,
the study product must always be suspect. To help assess, the following guidelines are
used.
Related – The AE is known to occur with the study agent, there is a reasonable
possibility that the study agent caused the AE, or there is a temporal relationship
between the study agent and event. Reasonable possibility means that there is
evidence to suggest a causal relationship between the study agent and the AE.
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Not Related – There is not a reasonable possibility that the administration of the
study agent caused the event, there is no temporal relationship between the study
agent and event onset, or an alternate etiology has been established.
3.7.2.3 Expectedness
Expected adverse reactions are AEs that are common and known to occur for the
study agent being studied and should be collected in a standard, systematic format using a
grading scale based on functional assessment or magnitude of reaction. An AE or suspected
adverse reaction is considered "unexpected" if it is not listed in the IB or is not listed at the
specificity or severity that has been observed; or, if an IB is not required or available, is
not consistent with the risk information described in the general investigational plan or
elsewhere in the protocol, as amended.
Medical Investigators (i.e., the subject’s physician) will be responsible for
determining whether an AE is expected or unexpected. An AE will be considered
unexpected if the nature, severity, or frequency of the event is not consistent with the risk
information previously described for Minecraft.
3.7.3

Time Period and Frequency for Event Assessment and Follow-up

The occurrence of an AE or SAE may come to the attention of study personnel
during study visits and interviews of a study participant presenting for medical care, or
upon review by a study monitor. All AEs including local and systemic reactions not
meeting the criteria for SAEs will be captured on the appropriate CRF. Information to be
collected includes event description, time of onset, clinician’s assessment of severity,
relationship to study product (assessed only by those with the training and authority to
make a diagnosis), and time of resolution/stabilization of the event. All AEs occurring
while on study must be documented appropriately regardless of relationship. All AEs will
be followed to adequate resolution.
Any medical condition that is present at the time that the participant is screened
will be considered as baseline and not reported as an AE. However, if the study
participant’s condition deteriorates at any time during the study, it will be recorded as an
AE. UPs will be recorded in the data collection system throughout the study.
Changes in the severity of an AE will be documented to allow an assessment of the
duration of the event at each level of severity to be performed. AEs characterized as
intermittent require documentation of onset and duration of each episode.
The PI will record all reportable events with start dates occurring any time after
informed consent is obtained until 7 (for non-serious AEs) or 30 days (for SAEs) after the
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last day of study participation. At the study visit, the investigator will inquire about the
occurrence of AE/SAEs since the initial visit. Events will be followed for outcome
information until resolution or stabilization.
3.7.4

Reporting Procedures

3.7.4.1 Adverse Event Reporting
Responsible Parties
Sponsor/Investigator/ Safety Officer- Robert Lodder
Other Investigators - Medical Investigators (site PIs), Adriane Grumbein, and Kyra
Hunting
The Sponsor-Investigator/Safety Officer will inform the IRB of any events of which he
becomes aware of.
3.7.4.2 Serious Adverse Event Reporting
Safety reports will be made of potential serious risks, from clinical trials or any
other source, as soon as possible, but in no case later than 14 calendar days after the sponsor
determines that the information qualifies for reporting.
The PI will report any suspected adverse reaction that is both serious and
unexpected. The sponsor must report an adverse event as a suspected adverse reaction only
if there is evidence to suggest a causal relationship between the therapeutic agent and the
adverse event, such as:
(A) A single occurrence of an event that is uncommon and known to be strongly
associated with drug exposure (e.g., angioedema, hepatic injury, Stevens-Johnson
Syndrome);
(B) One or more occurrences of an event that is not commonly associated with drug
exposure, but is otherwise uncommon in the population exposed to the drug (e.g., tendon
rupture);
(C) An aggregate analysis of specific events observed in a clinical trial (such as
known consequences of the underlying disease or condition under investigation or other
events that commonly occur in the study population independent of drug therapy) that
indicates those events occur more frequently in the drug treatment group than in a
concurrent or historical.
Life-threatening suspected adverse reaction as soon as possible but in no case later
than 7 days after sponsor determines that the information.
The study clinician will complete a SAE Form within the following timelines:
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Figure 6 - Adverse Events Reporting in Therapeutic Video Games Pilot Study
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All deaths and immediately life-threatening events, whether related or unrelated,
will be recorded on the SAE Form and submitted to the study sponsor within 24 hours of
site awareness.
Other SAEs regardless of relationship, will be submitted to the study sponsor within
24 hours of site awareness.
All SAEs will be followed until satisfactory resolution or until the site investigator
deems the event to be chronic or the adherence to be stable. Other supporting
documentation of the event may be requested by the study sponsor and should be provided
as soon as possible.
The study sponsor will be responsible for notifying IRB of any unexpected fatal or
life- threatening suspected adverse reaction as soon as possible but in no case later than 7
calendar days after the sponsor's initial receipt of the information.
3.7.4.3 Unanticipated Problem Reporting
Incidents or events that meet the OHRP criteria for UPs require the creation and
completion of an UP report form. It is the site investigator’s responsibility to report UPs to
their IRB. The UP report will include the following information:
Protocol identifying information: protocol title and number, PI’s name, and the IRB
project number;
A detailed description of the event, incident, experience, or outcome;
An explanation of the basis for determining that the event, incident, experience, or
outcome represents an UP;
A description of any changes to the protocol or other corrective actions that have
been taken or are proposed in response to the UP.
To satisfy the requirement for prompt reporting, UPs will be reported using the
following timeline:
UPs that are SAEs will be reported to the IRB within 7 days of the investigator and
to the sponsor within 24 hours of the investigator becoming aware of the event.
Any other UP will be reported to the IRB and to the study sponsor within 14 days
of the investigator becoming aware of the problem.
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All UPs should be reported to appropriate institutional officials (as required by UK
per Serious or Continuing Noncompliance or Unanticipated Problems Involving Risks:IRB
Reporting to Federal Agencies using the UK IRB reporting form within the timeline in
accordance with the SOP for Unanticipated/Anticipated Problem/Adverse Event Reporting
(UK) of the IRB’s receipt of the report of the problem from the investigator.
3.7.4.4 Events of Special Interest
Not applicable.
3.7.4.5 Reporting of Pregnancy
Report as a non-treatment related AE to the IRB. Physicians will ultimately make
the decision as to whether to continue the drugs they have prescribed. If subjects are
removed from their ADHD pharmaceutical regimen then participants will be discontinued
from study. Subjects that remain on the ADHD pharmaceutical regimen will continue in
the study.
3.7.5

Study Halting Rules

Administration of study agent will be halted when three severe AEs determined to
be “probably related” are reported to the Study Coordinator. The Study Coordinator will
notify the study sponsor and investigators immediately when the third severe event is
reported and enrollment screens will stop accepting new study participants. The study
sponsor will inform the IRB within 24 hours of this occurrence and will provide the IRB
with AE listing reports. The Investigative team, medical investigators, and CCTS will
convene an ad hoc meeting by teleconference or in writing as soon as possible.
3.7.6

Safety Oversight

As overall risk of this study is extremely low due to use of subjects’ normal standard
of care FDA approved pharmaceutical and a non-rated, fairly innocuous video game (No
language concerns, limited violence (i.e. cartoon skeletons shooting arrows and scary cave
noises), as well as portals to the Nether). Therefore, a data safety management board will
not be used. Safety oversight will be under the direction of the Monitor, with prior expertise
in clinical monitoring. The Monitor will inspect the CCTS site at least once to assess data
in the study. The Study Monitor will provide its input to the study sponsor.

3.8

Clinical Monitoring

Our designated monitor will conduct the monitoring. The monitor has experience
monitoring other human trials. Monitoring will include an on-site initiation visit and close
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down visit. Additional remote monitoring will be conducted to verify data by our auditor.
Data verification will be comprehensive (100%) of the primary endpoint. Secondary
endpoint verification of data will be more random with at least 10% of data verified. The
monitor will also distribute monitoring reports to the Sponsor/Investigator and our research
coordinator at CCTS.
Independent audits will not be conducted to ensure monitoring practices are
performed consistently across all participating sites.
CCTS will perform internal quality management of study conduct, data collection,
documentation and completion. An individualized quality management plan will be
developed to describe the site’s quality management.

3.9
3.9.1

Statistical Considerations
Statistical and Analytical Plans

This is a pilot study to investigate video game use as an add-on to stimulant type
ADHD medications.
3.9.2

Statistical Hypotheses

None. This is an exploratory data analysis to look for relationships between game
design factors and NICHQ scores and executive functions.
3.9.3

Analysis Datasets

Safety Population - All subjects who play at least one day on the trial Minecraft
realm will be included in the safety analyses. All adverse events reported in this study will
be listed and tabulated using descriptive statistics, frequencies, and proportions.
Intent-to-Treat (ITT) Analysis Dataset will include all randomized subjects.
Per-Protocol (PP) Analysis Dataset: All subjects with a pre- and post-trial NICHQ
questionnaire scores and completed at least 80% of each of the components of the study.
3.9.4

Description of Statistical Methods

3.9.4.1 General Approach
This is a pilot study with a parallel design in which one group plays Minecraft and
the other group does not. Both groups will already be receiving the ADHD standard of care
stimulant drugs. No preliminary data are available and there are no expectations regarding
the results. This pilot study will enable us to propose further studies with testable statistical
hypotheses.
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Exploratory data analysis (EDA) techniques will be used for analysis. EDA is an
approach to analyzing data sets to summarize their main characteristics, often with visual
methods. A statistical model may or may not be used, because the purpose of EDA is
primarily to see what the data can tell us beyond a formal modeling or hypothesis testing
task. Typical EDA modeling techniques include: box plot, histogram, Multi-vari chart, run
chart, pareto chart, scatter plot, stem-and-leaf plot, parallel coordinates, odds ratio,
multidimensional scaling, targeted projection pursuit, principal component analysis (PCA),
multilinear PCA, projection methods such as grand tour, guided tour, and manual tour,
interactive versions of the plots, single linkage cluster analysis, and other forms of
hierarchical clustering methods. Quantitative techniques that may be applied include
median polish, trimean, and ordination to distinguish related patterns. Post hoc tests of
significance may be performed. In addition, exploratory data analysis enables checks of
assumptions (e.g., normality) underlying statistical procedures.
3.9.4.2 Analysis of the Primary Efficacy Endpoint(s)
For the primary endpoint, due to the small sample size and the fact that this is a
pilot study, exploratory data analysis will be used. Data to be collected includes pre-play
and post-play NICHQ questionnaire scores, drugs and doses, and executive functions
played out in Minecraft. We will be looking for correlation trends and goodness of fit of
linear and nonlinear models as well as the presence of covariates and factors in the
predictive model for NICHQ scores.
All attempts will be made to prevent any missing values. Data imputation may be
done as part of EDA. For the analysis of the primary endpoint (NICHQ values), the Last
Observation Carried Forward (LOCF) concept will be used for subjects who discontinue
prematurely from the study. These results will be compared with those obtained by the use
of data splines. If for any reason the final NICHQ assessments from teachers are not
available, the study will simply treat them as missing data and continue with only the
assessments from the parents.
Data points that appear to be erroneous or inexplicable based on clinical judgment
will be investigated and considered outliers. If a data point is identified as an outlier, two
analyses will be performed, one with the outlier data point and one without the outlier. All
data points will be reported in the listings, including any data point that may have been
identified as an outlier. No data points will be excluded from the listings.
3.9.4.3 Analysis of the Secondary Endpoint(s)
Secondary Endpoint exploratory data analysis will include subject reflection data,
number of Minecraft assigned activities completed, subject-reported compliance rate of
game play and pharmaceutical use, Minecraft Realm history, sex, age, and drugs and dose
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levels as the factors of interest. For missing data, models will be built with and without
data imputation and the results compared .
3.9.4.4 Safety Analyses
All subjects who play at least one day in the trial Minecraft realm will be included
in the safety analyses. All adverse events reported in this study will be listed and tabulated
using descriptive statistics, frequencies, and proportions.
Safety data will be analyzed for all subjects in the safety population. The safety
population is defined as all subjects who have signed the study Informed Assent Document
and have played at least one day in the Minecraft Realm. The safety variables that will be
analyzed, at the minimum, include all reported adverse events.
All adverse events (AEs) as defined by the Common Terminology Criteria for
Adverse Events155 (CTCAE) will be analyzed for safety and tolerability. All study
emergent adverse events (TEAEs) will be coded using the latest version of the MedDRA
dictionary.
The number and proportion of subjects who report any TEAE will be tabulated by
study group. All reported TEAEs will be summarized using descriptive statistics (n, mean,
median, range, SD, or number and percentage of subjects) per study group. Studyemergent adverse events are defined as those events occurring or worsening upon or after
receiving the first exposure to the randomized study agent (Minecraft). Adverse events will
be listed by study group and subject. For any inferential statistics, appropriate statistical
tests [Chi-square or Fisher’s exact tests for categorical variables and Analysis of Variance
(ANOVA) or Analysis of Covariance (ANCOVA) with the baseline value as the covariate
for continuous variables] will be used. These models along with their parameters will be
detailed in the SAP.
The Intent-to-Treat (ITT) population, safety population, and efficacy evaluable
population will be defined and described in detail as part of the Statistical Analysis Plan
(SAP). The SAP will be developed and finalized before the database is locked. This is a
pilot study of a videogame and it is not clear what kind of safety information will be
collected if any during the course of the trial. Information gathered during the interim
analysis may help in the design of the SAP.
3.9.4.5 Adherence and Retention Analyses
Minecraft Realms provides user statistics to allow some subject adherence analysis.
Additionally, users will be required to provide some user completion data of Minecraft
associated activities. All subjects will keep a log of video gaming play (all games, including
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Minecraft). The log will include dates, times, and specific video games played, which will
be analyzed for adherence and possible confounders.
3.9.4.6 Baseline Descriptive Statistics
Baseline demographic data will include age, sex, and race Baseline intervention
data will include NICHQ pre-study questionnaire scores, gaming history, and medical and
drug history.
3.9.4.7 Planned Interim Analyses
An interim analysis will be conducted by the PI two weeks after the study begins
to ensure the software is working properly and that all relevant data are being collected in
the CRF. Conducting an interim analysis will allow investigators to determine any issues
associated with subjects’ use of technology and/or missing data and resolve these issues
before database lock. There is no risk in conducting an interim analysis because the study
is not blinded
3.9.4.8 Additional Sub-Group Analyses
Both the primary and secondary endpoints will be analyzed based on age, sex, and
race.
3.9.4.9 Multiple Comparison/Multiplicity
Not applicable.
3.9.4.10

Tabulation of Individual Response Data

Individual participant data will be listed by measure and time point.
3.9.4.11

Exploratory Analyses

Exploratory analysis will be performed on the NICHQ scores, including:
Self-reflective scores, video gaming logs, drug use, and Minecraft Realm play by
subjects digitally saved during the trial will be analyzed post hoc. Exploratory data analysis
(EDA) is an approach to analyzing data sets to summarize their main characteristics, often
with visual methods. A statistical model may or may not be used, because the purpose of
EDA is primarily to see what the data can tell us beyond a formal modeling or hypothesis
testing task. EDA will be conducted to identify outliers, trends and patterns in data that
merit further study.
Types of exploratory procedure will include: box plot, histogram, multi-vari chart,
run chart, pareto chart, scatter plot, stem-and-leaf plot, parallel coordinates, odds ratio,
multidimensional scaling, targeted projection pursuit, principal component analysis,
principal curve analysis, multilinear PCA, projection methods such as grand tour, guided
tour and manual tour, interactive versions of these plots, single linkage cluster analysis, or
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other hierarchical clustering methods. Typical quantitative techniques that may be used
include median polish, trimean, and ordination.
3.9.5

Sample Size

The study will enroll 16 subjects (8 female, 8 male) at the UK Center for Clinical
and Translational Science (CCTS) with a previous medically confirmed diagnosis of
ADHD in order to have at least 12 complete the study. As this study is primarily
exploratory, no sample size calculations were performed. Having 6 subjects per group
allows a standard deviation to be calculated as well as a mean for each group, and also
minimizes the number of subjects exposed to the intervention in this preliminary pilot
study.
If a participant is lost to follow-up at any point during the trial the subject outcome
will be assessed in the intent to treat analysis under the principle of the last observation
carried forward (LOCF).
Statistical software used will include R and Matlab.
3.9.6

Measures to Minimize Bias

3.9.6.1 Enrollment/Randomization/Masking Procedures
The population of subjects with ADHD is predominantly male. The enrollment of
sexes between the two study arms will be equalized as much as possible. The enrollment
of different races and ages will also be equalized between the two arms as much as possible
within the constraints of the small sample size. Participants who discontinue early will not
be replaced.
The exploratory pilot study is open label and blinding procedures will not be
employed.
3.9.6.2 Evaluation of Success of Blinding
Not applicable.
3.9.6.3 Breaking the Study Blind/Participant Code
Not applicable.
3.10 Source Documents and Access to Source Documents
Appropriate medical and research records will be kept for this trial for a minimum
of 6 years. FDA and IRB personnel will be given access to source data as needed.
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Source Documents and Data
Participant files included in trial: CRFs, study compliance logs (gaming and
medication), self reflection questions, pre- and post-study completed NICHQ
questionnaires, and memoranda.
Software as a Service Vendor (SaaS) Models156
This project will use the multi-tenant infrastructure cloud provided by Google. The
inclusion criteria will limit subjects to those who are already using Google services. The
security and privacy controls are basically the same for everyone, with a few variations
such as two factor authentication which can be enabled or disabled by the subjects. (The
therapeutic video game (TVG) project can only be accessed with two-factor authentication
on, but individual subjects have the option of using two-factor authentication or leaving it
turned off for their own data). 21 CFR part 11 compliance is gained by a business associate
agreement with Google, by designing our security controls to interface with those specified
by the agreement with Google, and by following our SOP's (built around 21 CFR part 11
compliance). Google also employs version control making the trial documents, even those
completed by subjects, completely traceable. Version control, a standard feature of Google
Drive, allows researchers to monitor the date, ownership, and exact change made to any
source document, including assessments. Minecraft Realm administrator privileges also
allow the research team to access the individual playing time metrics to analyze for
discrepancies between actual time played versus the self reported playing time.
Platform as a Service (PaaS) vs. SaaS157
NIST defines PaaS as the capability provided to the user to deploy onto the cloud
infrastructure programs created by the user or acquired by the user. Acquired applications
are created using programming languages, libraries, services, and tools supported by the
provider. The purpose of PaaS is to provide a programming platform to create a software
application solution without the overhead of hosting and maintaining the underlying
technology stack.
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Figure 7 - Software as a Service (SaaS) Vendor Model
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Figure 8 - Platform as a Service (Paas) Vs. Software as a Service (Saas) Vendor Model
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NIST defines SaaS as the capability provided to the user to run the provider’s
applications executing on a cloud infrastructure. The applications are accessible from
various client devices through either a thin client interface, such as a web browser, or a
program interface. The user does not manage or control the underlying cloud infrastructure
including network, servers, operating systems, storage, or even individual application
capabilities, with the possible exception of limited user specific application configuration
settings.
Using both SaaS and PaaS enables the encryption of subject-provided data from a
SaaS system in a PaaS system (the Therapeutic Video Games or TVG Google PaaS).
Data stored will be encrypted using the OpenPGP standard as defined by RFC4880.
Data transmitted on networks will be encrypted by Transport Layer Security or
Secure Sockets Layer.
The list of subjects and ID numbers will be encrypted with a different key than the
key used to encrypt all of the other data.
Cloud services the subjects and their parents already use include Minecraft and
Google by the inclusion and exclusion criteria. These are all SaaS. The data aggregator to
collect the subjects information from Minecraft in Google must have access to Google
(PaaS) in order to create the backup at UK.
CCTS personnel, PI, the trial Monitor, and the trial Auditor will have access to
CRFs. CRF data will be recorded electronically because most of the data (which include
the Minecraft Realm evolution over 4 weeks as recorded for backup purposes in save-sets,
as well as subject reflections on gameplay for Minecraft, and logging of other video game
play are in large data sets and only available in electronic form. Other CRF data include
medical problems/issues, past illnesses as well as age at diagnosis, surgeries, amount of
time subjects spend playing video games, gaming platform, typical length of playing
session, video games previously played, age at which subject started playing, list/doses of
current prescription, otc, and herbal supplements being taken, and height/weight.
The de-identified CRF data listed above will be copied to a compact disk for
archiving. The de-identified data will also be available in the UK repository. The data will
be de- identified during the download process by removing fields tagged as identifiers as
part of the download process.
The CCTS study coordinator, will input the baseline NICHQ teacher scores into
the eCRF from paper records if a teacher test record exists in participants’ files that is no
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Figure 9 - Service Models for Therapeutic Video Games Pilot Study
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more than 1 month old, once subjects’ parents/legal guardians have given consent for the
information to be accessed.
Study and drug compliance records subjects make on their own Google Drives
(Google is an inclusion criterion), as well as study reflection questions, will be shared by
the subjects with the PI) online via Google, ensuring protection for data with personal
identifying information (PII) or personal health information (PHI). The PI will
automatically collect the shared data, which will be de-identified while still on Google and
downloaded for backup to a password-protected single-user computer behind a firewall.
Periodically and at the end of the study, the data will be downloaded to a passwordprotected compact disk.

3.11 Quality Assurance and Quality Control
QC procedures will be implemented beginning with the data entry system and data
QC checks for the database will be generated. Any missing data or data anomalies will be
communicated to the site(s) for clarification/resolution. If for any reason the final NICHQ
assessments from teachers are not available, the study will simply treat them as missing
data. However, the initial assessment must be available for enrollment.
The monitors will verify that the clinical trial is conducted and data are generated,
documented (recorded), and reported in compliance with the protocol, and GCP.
The investigational site will provide direct access to all trial related materials,
source data/documents, and reports for the purpose of monitoring and auditing by the
sponsor, and inspection by local and regulatory authorities.

3.12 Ethics/Protection of Human Subjects
3.12.1 Ethical Standard
The investigator will ensure that this study is conducted in full conformity with
Regulations for the Protection of Human Subjects of Research codified in 45 CFR Part 46,
21 CFR Part 50, 21 CFR Part 56, and/or the ICH E6.
3.12.2 Institutional Review Board
The protocol, informed consent/assent form(s), recruitment materials, and all
participant materials will be submitted to the IRB for review and approval. Approval of
both the protocol and the consent and assent forms must be obtained before any participant
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is enrolled. Any amendment to the protocol will require review and approval by the IRB
before the changes are implemented to the study. All changes to the consent form will be
IRB approved; a determination will be made regarding whether previously consented
participants need to be re-consented.
3.12.3 Informed Consent Process
3.12.3.1
Consent/Assent and Other Informational Documents Provided to
Participants
Consent forms describing in detail the study agent, study procedures, and risks are
given to the participant and written documentation of informed consent is required prior to
starting intervention/administering study product. The following consent materials are
submitted with this protocol: Informed Consent, Assent, web advertisement, activity list,
video gaming log, drug compliance log, example self-assessment question list.
There are two ways in which subjects may enter this trial. In the first way, subjects
will be referred by their physician. In this case, the physician will obtain informed consent
and assent. The second way is through advertisements. When a subject responds to an
advertisement, the subject will have first contact with the research coordinator in the CCTS,
and will be taken through the informed consent and assent process by the clinical research
coordinator in the CCTS. The medical investigator or clinical research coordinator will
explain the research study to the participant and answer any questions that may arise. The
participant of legal age will sign the informed consent document prior to any procedures
being done specifically for the study. A participant of less than legal age must sign an
assent form, while that person’s parent or guardian must sign the consent document. The
participants (i.e., the subject or the subject’s parent) may withdraw consent or assent at any
time throughout the course of the trial.
Informed consent is a process that is initiated prior to the individual’s agreeing to
participate in the study and continues throughout the individual’s study participation.
Extensive discussion of risks and possible benefits of participation will be provided to the
participants and their families. Consent forms will be IRB-approved and the participant
will be asked to read and review the document. The investigator will explain the research
study to the participant and answer any questions that may arise. All participants will
receive a verbal explanation in terms suited to their comprehension of the purposes,
procedures, and potential risks of the study and of their rights as research participants.
Participants will have the opportunity to carefully review the written consent form and ask
questions prior to signing. The participants should have the opportunity to discuss the study
with their surrogates or think about it prior to agreeing to participate. The participant will
sign the informed consent document prior to any procedures being done specifically for the
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study. The participants may withdraw consent at any time throughout the course of the
trial. A copy of the informed consent document will be given to the participants for their
records. The rights and welfare of the participants will be protected by emphasizing to them
that the quality of their medical care will not be adversely affected if they decline to
participate in this study.
3.12.3.2

Consent Procedures and Documentation

Informed consent is a process that is initiated prior to the individual’s agreeing to
participate in the study and continues throughout the individual’s study participation.
Extensive discussion of risks and possible benefits of participation will be provided to the
participants and their families. Consent and Assent forms will be IRB-approved and the
participant will be asked to read and review the document. The investigator will explain
the research study to the participant and answer any questions that may arise. All
participants will receive a verbal explanation in terms suited to their comprehension of the
purposes, procedures, and potential risks of the study and of their rights as research
participants. Participants will have the opportunity to carefully review the written consent
and assent form and ask questions prior to signing. The participants should have the
opportunity to discuss the study with their surrogates or think about it prior to agreeing to
participate. The participant will sign the informed consent / assent document prior to any
procedures being done specifically for the study. The participants may withdraw consent
or assent at any time throughout the course of the trial. A copy of the informed consent /
assent document will be given to the participants for their records. The rights and welfare
of the participants will be protected by emphasizing to them that the quality of their medical
care will not be adversely affected if they decline to participate in this study.
3.12.4 Participant and Data Confidentiality
Participant confidentiality is strictly held in trust by the participating investigators,
their staff, and their agents. This confidentiality is extended to cover testing of biological
samples and genetic tests in addition to the clinical information relating to participants.
Therefore, the study protocol, documentation, data, and all other information generated
will be held in strict confidence. No information concerning the study or the data will be
released to any unauthorized third party without prior written approval of the sponsor.
The study monitor, other authorized representatives of the sponsor, representatives
of the IRB may inspect all documents and records required to be maintained by the
investigator, including but not limited to, medical records (office, clinic, or hospital) and
pharmacy records for the participants in this study. The clinical study site will permit access
to such records.
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The study participant’s contact information will be securely stored at each clinical
site for internal use during the study. At the end of the study, all records will continue to
be kept in a secure location for as long a period as dictated by local IRB and Institutional
regulations.
Study participant research data, which is for purposes of statistical analysis and
scientific reporting, will be transmitted to and stored at the UK Data Repository and on
password protected CD. This will not include the participant’s contact or identifying
information. Rather, individual participants and their research data will be identified by a
unique study identification number. The study data entry and study management systems
used by clinical personnel and CCTS research staff will be secured and password protected.
At the end of the study, all study databases will be de-identified and archived at the UK
Data Repository.
3.12.4.1

Research Use of Stored Human Samples, Specimens, or Data

The investigator will assure that subject’s anonymity will be maintained. On CRFs
or other documents submitted for analysis, subjects will not be identified by their names,
but by an identification code. The investigator will keep a separate log of subjects’ codes
and names.
The data from this study may be used for additional analysis, but it will be coded
or blinded data. Data collected for this study will be analyzed and stored by Investigator.
After the study is completed, the de-identified, archived data will be transmitted to and
stored at the Investigator/Sponsor’s lab, under the supervision of PI, for use by other
researchers including those outside of the study. Permission to transmit de-identified raw
data to the designated UK data repository will be included in the informed consent.
3.12.5 Future Use of Stored Specimens
Not applicable.
3.13 Data Handling and Record Keeping
3.13.1 Data Collection and Management Responsibilities
All data will be entered on CRFs at each examination, reviewed and verified. To
ensure accurate, complete, and reliable data, Investigator/Sponsor will do the following:
Provide instructional material to study sites, as appropriate

60

Sponsor a start-up training session to instruct the investigators and study
coordinators. This session will give instruction on the protocol, how to complete
the CRFs, and study procedures.
Periodic visits will be made to the study site
Be available for consultation and stay in contact with study site personnel by mail,
telephone, and/or fax
Review and evaluate CRF data using standard computer algorithms to detect errors
in data collection
Conduct a quality review of the data base
To ensure the safety of participants in the study, and to ensure accurate complete,
and reliable data, the investigator will keep records including clinical notes, and subject
medical records in the subject fields as original source documents for the study. If requested
the investigator will provide the sponsor, applicable regulatory agencies, and applicable
IRB with direct access to original source documents.
Copies of the electronic CRF (eCRF) will be provided for use as source documents
and maintained for recording data for each participant enrolled in the study. Data reported
in the eCRF derived from source documents should be consistent with the source
documents or the discrepancies should be explained and captured in a progress note and
maintained in the participant’s official electronic study record.
Clinical data (including AEs, concomitant medications, and expected adverse
reactions data) will be entered into a file on Google Drive, a data capture system. Clinical
data will be entered directly from the source documents, if necessary.
This project will also use the multi-tenant infrastructure cloud provided by Google.
The inclusion criteria will limit subjects to those who are already using Google services.
Data, such as drug and study compliance logs and subject evaluation questions, will be
uploaded to a secured Google Drive web page which uses Secure Sockets Layer for
transmission and shared with Dr. Robert Lodder by the subject. The security and privacy
controls are basically the same for everyone, with a few variations like two factor
authentication. (The TVG project can only be accessed with two factor authentication on,
but individual subjects have the option of using two factor authentication or leaving it
turned off for their own data). 21 CFR part 11 compliance is gained by a business associate
agreement with Google, by designing our security controls to interface with those specified
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by the agreement with Google, and by following our SOP's (built around 21 CFR part 11
compliance).
3.13.2 Study Records Retention
In order to comply with HIPAA requirements, IRBs generally require investigators
to retain research records for six years after completion of the study158. However, most
FDA regulations require records be kept at least 2 years post-marketing approval, which
could be as long as 10-15 years in this particular case. Therefore, records will be kept
minimally 6 years but possibly up to 15 years by the Sponsor/Investigator. Records, which
are expected to be only electronic, will be maintained in a secure fashion with limited
access, including additional controls to ensure password protection, authenticity, integrity,
confidentiality of electronic records.
3.13.3 Protocol Deviations
A protocol deviation is any noncompliance with the clinical trial protocol or GCP
requirements. The noncompliance may be either on the part of the participant, the
investigator, or the study site staff. As a result of deviations, corrective actions are to be
developed by the site and implemented promptly.
These practices are consistent with ICH E6:
Compliance with Protocol, sections 4.5.1, 4.5.2, and 4.5.3
Quality Assurance and Quality Control, section 5.1.1
Noncompliance, sections 5.20.1, and 5.20.2.
It is the responsibility of the site to use continuous vigilance to identify and report
deviations within 7 working days of identification of the protocol deviation, or within 7
working days of the scheduled protocol-required activity. All deviations must be addressed
in study source documents, reported to PI. Protocol deviations must be sent to the local
IRB per their guidelines. The site PI/study staff is responsible for knowing and adhering to
their IRB requirements.
3.13.4 Publication and Data Sharing Policy
This study will comply with the NIH Public Access Policy, which ensures that the
public has access to the published results of NIH funded research. It requires scientists to
submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital
archive PubMed Central upon acceptance for publication.
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The International Committee of Medical Journal Editors (ICMJE) member journals
have adopted a clinical trials registration policy as a condition for publication. The ICMJE
defines a clinical trial as any research project that prospectively assigns human subjects to
intervention or concurrent comparison or control groups to study the cause-and-effect
relationship between a medical intervention and a health outcome. Medical interventions
include drugs, surgical procedures, devices, behavioral treatments, process-of-care
changes, and the like. Health outcomes include any biomedical or health-related measures
obtained in patients or participants, including pharmacokinetic measures and adverse
events. The ICMJE policy, and the Section 801 of the Food and Drug Administration
Amendments Act of 2007, requires that all clinical trials be registered in a public trials
registry such as ClinicalTrials.gov, which is sponsored by the National Library of
Medicine. Other biomedical journals are considering adopting similar policies. For
interventional clinical trials performed under NIH IC grants and cooperative agreements,
it is the grantee’s responsibility to register the trial in an acceptable registry, so the research
results may be considered for publication in ICMJE member journals. The ICMJE does not
review specific studies to determine whether registration is necessary; instead, the
committee recommends that researchers who have questions about the need to register err
on the side of registration or consult the editorial office of the journal in which they wish
to publish.

3.14 Study Administration
3.14.1 Study Leadership
The Steering Committee will govern the conduct of the study. The Steering
Committee will be composed of the Study PI, Co-Investigators, and Medical Investigators.
The Steering Committee will meet in person as needed.

3.15 Conflict of Interest Policy
The independence of this study from any actual or perceived influence, such as by
the pharmaceutical industry, is critical. Therefore any actual conflict of interest of persons
who have a role in the design, conduct, analysis, publication, or any aspect of this trial will
be disclosed and managed. Furthermore, persons who have a perceived conflict of interest
will be required to have such conflicts managed in a way that is appropriate to their
participation in the trial. The study leadership as well as the University of Kentucky has
established policies and procedures for all study group members to disclose all conflicts of
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interest and will establish a mechanism for the management of all reported dualities of
interest. However, there are currently no conflicts of interest to disclose at this time among
study leadership members.
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CHAPTER 4. COMPUTATIONAL MODEL
4.1

The Virtual “Subject” as a Computational Model

To enable the computational simulation of tasks requiring the use of executive
functions in humans, computational models representing the executive functions working
memory and fluid intelligence were constructed. An impulsivity function was also built as
a first step towards the construction of a model for the behavioral inhibition executive
function. These virtual executive function models and the impulsivity function were then
combined in a virtual Time Management activity requiring their combined use for its
completion. In this context, the virtual “subject” is defined as the combination of the
executive function models within the Time Management activity (Figure 10).
Unique virtual “subjects” can be designed by varying the parameters of the
executive function and impulsivity models. The working memory and fluid intelligence
models contain ANNs, but the impulsivity function does not. As a result, the performance
of the working memory and fluid intelligence models can be modified by varying the
training parameters for their respective ANNs, but modification of the impulsivity function
requires manual manipulation of its parameters.
In this first implementation of the model, different groups of virtual “subjects” are
created by varying the training procedures of ANNs to form groups that differ in the level
of performance in the tasks that these ANNs are trained to perform. The training variations
introduced here include the number of training examples presented to the ANNs during
their learning and the duration of their training. When the efforts of multiple ANNs trained
to perform single tasks are combined to work together on a larger, more complicated task,
there will be a complex relationship between the set of training parameters for all the ANNs
and performance on the larger task. If this relationship is defined as a function that receives
the ANN training parameters as independent variables and transforms them into
performance on the larger task as the dependent variable, an optimization problem can be
created to maximize the improvement in performance that occurs with minimum variations
in training. If this model can be developed to possess a sufficient amount of translational
applicability to human subjects with executive function deficits, then the results of the
optimization could provide guidance for designing interventions to treat these executive
function deficits in humans.
4.2

Generating Working Memory Deficiencies (Colab Notebook)

As a first step towards the creation of a computational model of working memory
deficiencies, convolutional neural networks (CNNs) were trained to identify handwritten
digits in the MNIST dataset. The Keras Machine Learning library159 was used to create and
train the CNNs and the experiment was run in a Google Colaboratory Notebook. In this
implementation, the input of an MNIST image file into the first layer of the network is
proposed to represent the holding of information in consciousness
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Figure 10 – Building the Virtual “Subject”
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component of working memory. The subsequent processing of this image pixel data by the
internal network layers is proposed to represent the information manipulation component
of working memory. Two groups of CNNs were created by varying the number of MNIST
images (the size of the training set) used in their learning process. A “healthy” control
working memory group consisted of CNNs trained to achieve high accuracy in the
handwritten digit recognition task, while a “deficient” working memory group consisted of
CNNs trained to achieve approximately half the accuracy of the “healthy” control group.
All of the CNNs in both groups possessed an identical architecture, or structure of
layers and connectivity between individual units. The architecture chosen was a modified
version of the original historical CNN called lenet that was developed to identify
handwritten digits in MNIST to automate zip code recognition for postal service28,160. The
CNN architecture used here consist of two sets of convolutional and pooling layers,
followed by two fully-connected layers, and a softmax classifier. As discussed in Chapter
1, each unit in a convolutional layer is only connected to a limited set of the inputs provided
by the previous layer. The first convolutional layer in a CNN receives the input data to the
network (the image files themselves) as its input. The units in a convolutional layer are
arranged in a three dimensional rectangular shape, and the units in each two dimensional
“slice” of this rectangle shares the same set of weights and biases. The shared set of weights
& biases for the units in each slice is called the kernel, and can be thought of as a filter that
slides across the layer’s input to detect features that are used for determining the final
output of the CNN. Each convolutional layer is followed by a pooling layer that reduces
the number of parameters of the network by reducing the size of the convolutional layer’s
output before it is used as an input for subsequent layers. Similar to the units in a
convolutional layer, each unit in a pooling layer is also connected to a limited set of inputs
and simply saves the maximum value of the inputs it receives. The two fully-connected
layers reduce the quantity of outputs from the convolutional and pooling layers to the
number of classes that the model predicts. In the case of the MNIST dataset, which contains
images of the numbers 0-9, there are ten different classes. Finally, the softmax classifier162163
normalizes the output of the final fully-connected layer so that the sum of the outputs is
equal to 1. This modification allows the interpretation of the final outputs of the network
as a set of probabilities that the input to the network falls into each prediction class. For
example, the CNN’s output for a given MNIST image consist of a set of 10 values, each of
which represents the probability that the image contains a handwritten digit of one of the
numbers 0-9.
The structure of the CNN was modified by including a batch normalization layer163
with each convolutional layer and using the rectified linear unit (ReLU) activation
function164. The batch normalization layers reduce the magnitude of the variability in their
inputs by subtracting each input by the mean of all inputs and then dividing each meancentered input by the standard deviation of all inputs. These layers are located after each
convolutional layer and after the first fully connected layer of the network. They receive
the net inputs calculated by the preceding layer, and the normalized outputs they calculate
are passed on as inputs for the ReLU activation function. The ReLU activation function
returns an output of zero for all input values < 0, and returns the original input value for all
input values > 0. Batch normalization layers help reduce overfitting of a neural network
to training data, and the use of the ReLU activation function hastens the training time for
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neural networks by avoiding the vanishing gradient problem161 associated with the use of
other activation functions.
To generate deficiencies in this working memory representation, the relationship
between the quantity of training examples and handwritten digit recognition performance
of CNNs was first investigated. Five groups of identically structured CNNs (n = 10 x
CNNS per group) were trained with sets of MNIST images with sizes in the range of 25 –
50000 MNIST images per set. The MNIST images used for training were randomly
selected from the training subset of the MNIST dataset, and randomly selected sets
containing less than 100 MNIST images were checked to ensure that they contained at least
one example image of each handwritten digit 0-9. Updates of the CNN parameters (weights
& biases) were performed after training on batches of 25 MNIST images. The categorical
cross-entropy loss function161 was used to measure the handwritten digit recognition
performance of the CNNs during training and calculate the gradients of its weights and
biases. The ADAM optimizer165 was then used to calculate the magnitude of the parameter
updates from these gradients.
After training, the percent accuracy of handwritten digit recognition performance
of each CNN was evaluated on the 10,000 MNIST images of the MNIST test set, and the
mean accuracy of each group of CNNs was determined. As expected, the group mean
handwritten digit recognition accuracy increased with increasing number of MNIST
images presented during training (Figure 11). The minimum group accuracy achieved was
44.3% (SD 4.1%) with 25 MNIST training images, and the maximum group accuracy
achieved was 98.2% (SD 0.5%) with 50,000 MNIST training images. The observed
relationship between group accuracy and the number of MNIST training images was
logarithmic, and the rate of increase in performance was relatively minimal in groups
trained with set sizes larger than 2,500 MNIST images (mean group accuracy = 95.7% (SD
0.5%)).
Training procedures for the CNNs representing working memory in the virtual
Time Management Task were selected to create a sizeable difference in performance
between the “healthy” working memory control group with high handwritten digit
recognition performance and the “deficient” working memory group with poor handwritten
digit recognition performance in a minimal amount of computational time. Computational
efficiency was prioritized over marginal improvements in accuracy in the selection of a
training procedure for the “healthy” working memory control group. While a 2.5%
improvement in group accuracy was observed from increasing the training set size from
2,500 to 50,000 MNIST images, this improvement was achieved at a significant cost of
increased computational time. Thus, a training set size of 2,500 MNIST images was
selected to efficiently train CNNs in the “healthy” working memory control group to
achieve a sufficiently high handwritten digit recognition performance.
The selection of a training procedure for the “deficient” working memory group
was based on a similar consideration of weighing the level of performance achieved with
the training time required to achieve the performance. A large performance decrement
compared to the “healthy” working memory group was desirable in this case. The
minimum accuracy achieved in this experiment was 44.3% (SD 41%) in the group trained
with 25 MNIST images. While this level of accuracy could be decreased further by
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Figure 11 – Effect of MNIST Training Set Size on MNIST TestSet Handwritten Digit
Recognition of CNNs (n = 10 x CNNs per Group)
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reducing the size of the training set, this decrease was achieved at a cost of significantly
increased computational time to randomly select smaller training sets with at least one
MNIST image containing each handwritten digit. Thus, a training set size of 25 MNIST
images was selected to efficiently train CNNs in the “deficient” working memory group to
achieve a sizable reduction in handwritten digit recognition performance compared to the
“healthy” working memory control group.
To summarize, this investigation was performed to select training procedures for
MNIST handwritten digit recognition by CNNs as a computational representation for
working memory in humans. In this context, a “healthy” working memory was defined as
high handwritten digit recognition performance by CNNs and a “deficient’ working
memory was defined as poor handwritten digit recognition performance by CNNs.
Differences in performance were created by varying the number of MNIST images used to
train the CNNs. A training set size of 2,500 MNIST images was selected to generate CNNs
with high handwritten digit recognition performance representing “healthy” working
memory, while a training set size of 25 MNIST images was selected to generate CNNs
with poor handwritten digit recognition performance representing “deficient” working
memory.
4.3

Prepotent Impulsivity

As a first step towards the construction of a computational model for the behavioral
inhibition executive function, the prepotent impulsivity function was created to generate
impulsive behavior that may be inhibited. Prepotent responses are defined as unproductive
behaviors that have been overlearned in a given circumstance, and are then used
indiscriminately in other circumstances where they may no longer be appropriate7. This
function was designed to be an addition to the MNIST handwritten digit recognition
representation of working memory and activates unproductive behaviors resembling
prepotent responses in this context.
When the CNNs representing working memory were evaluated for their
performance, their handwritten digit recognition accuracy was determined on an ordered
test set. In other words, the CNNs were first presented with all the images containing a
handwritten zero, then all the images containing a handwritten one, all the images
containing a handwritten two, and so on. In contrast, this experiment was conducted with
shuffled test sets where the images containing the various handwritten digits were
presented to the CNNs in a random order. A shuffled test set will contain sub-sequences of
different images containing the same handwritten digit. When these sub-sequences with
consecutive images containing the same handwritten digit are presented to a CNN, a
prepotent impulse is created. This prepotent impulse grows in strength as the number of
consecutive digit repeats grows larger and promotes an automatic response with the
identity of the repeated digit from the virtual “subject”. The automatic prepotent response
is produced without the presentation of an MNIST image to the CNN, and is more likely
to be incorrect than a non-impulsive response produced with the presentation of an MNIST
image to the CNN. Thus, the prepotent impulsivity function can be considered a method to
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produce erratic behaviors without the benefit of reasoning with executive functions
(working memory) in this model.
In addition to the prepotent impulse, the prepotent impulsivity function also
includes a competing executive function-activating component. The executive functionactivating component supports the activation of a response determined by executive
functions, specifically the presentation of an MNIST image to the CNN. The probability
of carrying out an impulsive prepotent response is determined by subtracting the strength
of this executive function-activating component from the strength of the prepotent impulse
(Figure 12).
Both the prepotent impulse and the executive function-activating component of the
prepotent impulsivity function are Gaussian curves constructed with a strength parameter,
an efficiency parameter, and a delay parameter. These curves are calculated with
normalized time as the independent variable; this variable is considered an abstract
representation of computational processing time and not a real time related to the
computational task. The maximum values at the curves’ peaks are used to calculate the
prepotent response probability. The strength parameter determines the magnitude of the
curve’s peak, the efficiency parameter determines the rate at which the curve reaches its
peak, and the delay parameter determines the location where the curve begins to grow.
While the values of the parameters for the executive function-activating curve stay constant
as the evaluation of the shuffled test set proceeds, the magnitude of the strength parameter
for the prepotent impulse curve increases at a constant rate as MNIST images containing
the same handwritten digit are encountered consecutively.
The purpose of the prepotent impulsivity experiment was to determine whether this
model could produce a significant difference in the performance of the working memory
function. All calculations were performed with Wolfram Mathematica v11.1. In this
experiment two groups of CNNs (n = 6 x CNNs per group) were generated with the training
procedures described in Section 4.2 to produce a working memory deficient group and a
“healthy” working memory group and their baseline handwritten digit recognition accuracy
was evaluated on the MNIST test set. Both groups were then evaluated on six trials of
shuffled test sets with the addition of the prepotent impulsivity function (all group
“subjects” were evaluated with the same shuffled test set in each trial). The prepotent
response was simply a repeat of the response given for the previously encountered image
without giving the current MNIST image as an input to a CNN, while a non-impulsive
response was generated by the CNN after presentation with the current MNIST image as
an input. Both the difference in handwritten digit recognition performance between groups
and the differences in handwritten digit recognition within each group with the addition of
the prepotent impulsivity function were tested for significance with the Mann-Whitney U
test.
Results of this experiment are shown in Figure 13. After training for MNIST
handwritten digit recognition, the “healthy” working memory group achieved a mean
accuracy of 98.8% (SD 0.1%) while the “deficient” working memory group achieved a
mean accuracy of 56.6% (SD 3.7%) on the MNIST test set. With the addition of the
prepotent impulsivity function the “healthy” working memory group achieved a group
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Figure 12 – Effects of Repeated Handwritten Digits on Prepotent Impulsivity Function
(PI = Prepotent Impulse; EF = Executive Function-Activating Component; PR = Prepotent
Response Probability)
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Figure 13 – Effects of Prepotent Impulsivity Function on Group Mean Handwritten Digit
Recognition Accuracy of CNNs on MNIST TestSet (n = 6 x CNNs per Working Memory
Group)
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mean accuracy of 89.9% (SD 0.2%) while the “deficient” working memory group achieved
a group mean accuracy of 47.1% (SD 3.0%). Both the baseline difference in performance
between the two working memory groups, and the differences in performance within each
group resulting from the addition of the prepotent impulsivity function were significant.
These results indicate that a statistically significant difference in handwritten digit
recognition performance could be produced in both the “healthy” and “deficient” working
memory groups with the addition of the prepotent impulsivity function.
4.4

Generating Fluid Intelligence Deficiencies (Colaboratory Notebook)

The higher order executive function fluid intelligence has been described in terms
of the mental processes of analysis and synthesis7. The process of analysis involves the
decomposition of complex information into smaller, simpler parts, while the process of
synthesis involves the combination of simple pieces of information into more complex,
novel combinations. The generation of sets of factors of the number 12 by basic recurrent
neural networks (RNNs) is used as a representation of the synthesis component of fluid
intelligence in this experiment, as the simple integers 1-10 are combined in varying ways
until the more complex number 12 is produced.
While CNNs are only capable of processing a single input at a time, RNNs are
capable of processing sequences consisting of multiple inputs29. Although the architectures
of RNNs can vary considerably in complexity, the simplest form of RNN possesses a single
internal layer that changes its state as the sequence is processed and three sets of weight
parameters. One set of weights processes the input to the network, another set of weights
modifies the state of the internal layer of the network, and the third set of weights converts
the inner state of the network into an output. The inner state of the network changes as each
individual element of the input sequence is processed in a series of steps; this inner state is
affected by the current element being processed as well as all the previously processed
elements and determines the output that the network produces at each step. As a result, the
output of the network at each step depends on both of the previously processed elements
of the sequence and the currently processed element.
To produce a list of integers that are factors of the number 12, the RNN produces a
single predicted factor at each step, this predicted factor is recorded in a list containing all
the previously predicted factors, and this set of previously predicted factors can then be
used as an input for the RNN in the next step (Figure 14). This process repeats until the
RNN produces an output indicating the output sequence is complete.
All calculations for this experiment were performed with Python v3 in a Google
Colaboratory Notebook. A basic RNN model modified from a RNN designed for language
modeling and the generation of reddit comments166 was implemented. This RNN contained
a single inner layer of 100 units, used the tanh activation function (a non-linear function
with outputs ranging from -1 to 1) to calculate the inner layer, and a softmax activation
function to generate a list of normalized probabilities for integers in the range 1-11 as an
output. The number 0 was used as a “start token”, or initial
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Figure 14 – Factor Prediction for the Number 12 by a Recurrent Neural Network
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input to signal the start of a factorization prediction, while the number 11 was used as an
“end token” to indicate the end of a sequence of predicted outputs.
A training set composed of 29 training examples with features (inputs) and labels
(correct outputs) were generated by hand. The set of training features consisted of lists of
integers between 0 and 10, and the list for each training feature began with the integer 0.
Lists of integers that could be multiplied together to produce the number 12 and lists of
integers that that could not be multiplied together to produce the number 12 were both
included. The set of training features lists that produced the number 12 included all the
permutations of each set of factors, while the training features lists that did not produce the
number 12 simply consisted of the start token 0 followed by the incorrect factor. A
matching training label was created for each training feature. The training label for each
example contained the same list of integers contained in the features for the example, but
the start token 0 was removed and the end token 11 was added to the end of the list.
Similar to the working memory function, modifications in a supervised learning
training procedure were investigated to produce different categories of performance for the
factorization of 12 in RNNs. In this case, the data available for training was limited (29
training examples vs. 50,000 MNIST training examples) so the differences in performance
were created by varying the number of training cycles (or epochs) as the independent
variable rather than the number of training examples presented. All of the training
examples are presented to a neural network in one training epoch, so the number of times
a neural network sees each training example is equivalent to the number of training epochs.
Ten groups of 12 x RNNs per group were assigned unique durations for their training
ranging from 1 training epoch to 5,000 training epochs. The categorical cross-entropy loss
function was used to measure the deviation between RNN outputs and correct predictions
and calculate gradients to adjust parameter values. Stochastic gradient descent with a
learning rate of 0.005 was used for the optimization method to adjust parameter values.
After training, the performance of each RNN was evaluated by calculating its
percent accuracy on 100 factorization of 12 predictions. As expected, the mean percent
accuracy for the RNNs in each group increased with the number of training epochs in a
logarithmic relationship (Figure 15). The minimum group mean accuracy was 0.5 % (SD
0.9%) for the RNN group trained for 1 epoch while the maximum group mean accuracy
achieved was 81.1% (SD 2.9%) for the RNN group trained for 5,000 epochs. The rate of
improvement in performance began to level off at a group mean accuracy of 74.2% (SD
5.4%) with 250 training epochs, although significant improvements in performance were
still observed as the number of training epochs was increased further.
The training procedure for “deficient” fluid intelligence RNNs was selected to
achieve a goal of approximately 50% mean factorization of 12 accuracy, while the training
procedure for “healthy” fluid intelligence RNNs was selected with a consideration of
performance and computational efficiency. The goal performance level for “deficient”
fluid intelligence was achieved in RNNs trained for 75 epochs (group mean accuracy =
48.3% (SD 4.1%). Training for 1000 epochs was selected as the learning procedure for
“healthy” fluid intelligence RNNs to achieve a mean group accuracy of 77.6 % (SD 4.2%)
with a sacrifice of 3.5% accuracy in exchange for significantly improved computational
efficiency compared to training for 5000 epochs.
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Figure 15 – Effect of Number of Training Epochs on Mean Group Accuracy of
Factorization of 12 in Recurrent Neural Networks (n = 12 x RNNs Per Group)
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In summary, a computational representation for the synthesis function of the higher
order executive function fluid intelligence in humans was developed in this experiment.
This model includes basic RNNs to predict integers between 1 and 10 that can be multiplied
together to produce the number 12, where a “healthy” fluid intelligence is represented by
RNNs with high factorization of 12 accuracy and a “deficient” fluid intelligence is
represented by RNNs with poor factorization of 12 accuracy. This factorization of 12 fluid
intelligence function was then integrated together with the MNIST handwritten digit
recognition function representation for working memory and the prepotent impulsivity
function to create the first implementation of virtual “subjects” who perform a virtual Time
Management task.
4.5

Time Management Task (Colaboratory Notebook)

Similar to the fluid intelligence task described in Section 4.4, the goal of the Time
Management task is to create a list of integers between 1 and 10 that can be multiplied
together to produce the number 12. However, the process required to achieve this goal is
modified in three important ways. Firstly, the Time Management task is not complete after
a single factorization of 12 attempt, but rather continues until a successful factorization of
12 is completed (Figure 16). Secondly, the Time Management task requires the use of the
working memory function impeded by the prepotent impulsivity function for its
completion. The working memory function with prepotent impulsivity is used after the
prediction of a single factor to locate and correctly identify an MNIST image that contains
the predicted factor as its handwritten digit in the MNIST test set. Finally, the performance
of the Time Management task is measured by the total number of MNIST test set images
searched through to complete a successful factorization of 12 rather than the percentage of
successful factorizations.
The procedure to create virtual “subjects” who complete the virtual Time
Management task is simply a combination of the neural network training procedures
developed in the preceding sections of this chapter. Each virtual “subject” consists of a
working memory function consisting of a CNN trained for handwritten digit recognition in
the MNIST test set, a set of parameters for the prepotent impulsivity function that impedes
the performance of the working memory function, and a fluid intelligence function
consisting of an RNN trained to factorize the number 12. Two groups of virtual “subjects”
with n = 6 x virtual “subjects” per group are created: a control group with “healthy”
working memory and fluid intelligence and an “ADHD” group with “deficient” working
memory and fluid intelligence. Prepotent impulsivity was included in all “subjects” in both
groups with the control group possessing a set of parameters that leads to lower impulsivity
than the “subjects” in the “ADHD” group.
All computations for the Time Management task were performed with Python 3 in
a Google Colaboratory Notebook, and the creation and training of CNNs were performed
with the Keras Machine Learning Library. Data visualizations were created in Wolfram
Mathematica v11.1. ANNs for the virtual “subjects” in the control group were trained with
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Figure 16 – Recurrent Neural Networks (Fluid Intelligence) in the Time Management Task
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the learning procedures that produced 6x “healthy” working memory and 6x “healthy”
fluid intelligence representations, while ANNs for the virtual “subjects” in the ADHD
group were trained with the learning procedures that produced 6x “deficient” working
memory and 6x “deficient” fluid intelligence representations. All ANNs (CNNs and
RNNs) for each executive function representation possessed an identical architecture
across both groups as described for CNNs in Section 4.2 and for RNNs in Section 4.3.
“Healthy” working memory representations for six virtual control “subjects” were
produced by training each of six CNNs with 2,500 handwritten digit images randomly
selected from the MNIST training set and “deficient” working memories for six virtual
“ADHD subjects” were produced by training each of six CNNs with 25 randomly selected
MNIST training set images. Similarly, “healthy” fluid intelligence representations for six
virtual control “subjects” were produced by training each of six basic RNNs for 1,000
epochs to factorize the number 12 and “deficient” fluid intelligence representations for six
virtual “ADHD subjects” were produced by training each of six basic RNNs for 75 training
epochs. Baseline accuracies of the working memory representations were measured by
handwritten digit recognition by CNNs on the MNIST test set while baseline accuracies of
the fluid intelligence representations were determined on 100x factorization of 12 attempts
by RNNs. The Mann-Whitney U test was used to test for significant differences between
group means in baseline performance for each executive function representation.
After training and evaluation of baseline performance of all ANNs, the Time
Management task was performed by the virtual “subjects” (Figure 17). In the first step of
the task, the virtual “subject’s” fluid intelligence representation uses a basic RNN to
perform a single factor prediction. The identity of this factor is then provided to the virtual
“subject’s” working memory representation with prepotent impulsivity, and the virtual
“subject” begins to identify handwritten digits in randomly selected images from the
MNIST test set. The virtual “subject’s” prepotent impulsivity function is operational with
each identification, and may activate an automatic impulsive response where the virtual
“subject” simply responds with its previous handwritten digit recognition output rather than
using its working memory representation to identify the handwritten digit with a CNN. As
described in Section 4.3, the automatic impulsive response becomes more likely as multiple
MNIST images containing the same handwritten digit are encountered in succession. This
search continues until the predicted factor is located AND correctly identified in the
MNIST test set. Once the search is successfully completed, another factor prediction is
performed and this sequence of steps continues until a complete factor list is predicted and
all of its elements are correctly identified in the MNIST test set. If a correct factor list is
predicted one trial of the task is complete. Otherwise, this procedure is repeated until a
correct factor list is produced. Each virtual “subject” completed 25 successful
factorizations of 12 trials, and a mean MNIST test set images searched count for all the
trials was calculated for each “subject”. The Mann-Whitney U Test was then used to test
the group mean images searched counts for significant differences.
Without prepotent impulsivity, virtual “subjects” in the “healthy” control group
achieved a baseline group mean handwritten digit recognition accuracy of 95.9% (SD
0.9%) while virtual “subjects” in the “ADHD” group achieved a baseline group mean
handwritten digit recognition accuracy of 39.2% (SD 5.1%) on the MNIST test set (Figure
18).
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Figure 17 – Time Management Task Flowchart
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Figure 18 – Baseline Difference in Mean Group Accuracy of Handwritten Digit
Recognition on MNIST TestSet by Convolutional Neural Networks of Virtual “Subjects”
in the Time Management Task (n = 6 x CNNs Per Group)
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A Mann-Whitney U Test showed a significant difference between the groups (p = 0.025).
For comparison, in the Generating Working Memory Deficiencies experiment (Section
4.2) the CNN-group trained with a random set of 2,500 MNIST images achieved a mean
group accuracy of 95.7% (SD 0.5%), while the CNN-group trained with a random set of
25 MNIST images achieved a mean group accuracy of 44.3% (SD 4.1%) in handwritten
digit recognition on the MNIST test set. A Mann-Whitney U test comparing the results of
each group between different experiments resulted in non-significant differences for both
groups (p = 0.704 and p = 0.0577 for the “healthy” and “deficient” groups, respectively).
Taken together, these data indicate that a significant difference in performance of the
working memory function was successfully produced between the virtual “subjects” in the
“healthy” control and “ADHD” groups, and the working memory deficiency results in this
experiment were consistent with the results of the previous experiment.
Virtual “subjects” in the “healthy” control group achieved a baseline group mean
factorization of 12 accuracy of 79.5% (SD 4.0%) while virtual “subjects” in the “ADHD”
group achieved a baseline group mean factorization of 12 accuracy of 47.3% (SD 4.7%)
(Figure 19). A Mann-Whitney U Test revealed a significant difference between groups (p
= 0.025). For comparison, in the Generating Fluid Intelligence Deficiencies experiment
(Section 4.3) the RNN-group trained for 1,000 epochs achieved a mean group accuracy of
77.6% (SD 4.2%), while the RNN-group trained for 75 epochs achieved a mean group
accuracy of 48.3% (SD 4.1%) on the factorization of 12 activity. A Mann-Whitney U test
comparing the results of each group between different experiments showed non-significant
differences for both groups (p = 0.479 and p = 0.707 for the “healthy” and “deficient”
groups, respectively). Taken together, these data indicate that a significant difference in
performance of the fluid intelligence function was successfully produced between the
virtual “subjects” in the “healthy” control and “ADHD” groups, and the fluid intelligence
deficiency results in this experiment were consistent with the results of the previous
experiment.
Finally, virtual “subjects” in the “healthy” control group required a group mean of
37.4 (SD 2.5) MNIST test set images searched through, while virtual “subjects” in the
“ADHD” group required a group mean of 579.1 (SD 352.3) MNIST test set images
searched through to complete the virtual Time Management task (Figure 20). A MannWhitney U Test showed a significant difference between groups (p = 0.0025). These results
indicated that this model composed of virtual “subjects” built from executive function
representations of working memory and fluid intelligence with impulsivity that complete a
virtual Time Management task that requires the use of these executive function
representations was able to produce two groups of “subjects” with distinct levels of
performance in the virtual task.
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Figure 19 – Baseline Difference in Mean Group Accuracy of Factorization of 12 by
Recurrent Neural Networks of Virtual “Subjects” in the Time Management Task (n = 6 x
RNNs Per Group)
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Figure 20 – Performance of Virtual “Subjects” in the Time Management Task (n = 6 x
Virtual “Subjects” Per Group)
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CHAPTER 5. DISCUSSION
In summary, a virtual Time Management task utilizing convolutional neural
networks, recurrent neural networks, and the MNIST dataset was designed as a first step
towards the development of a virtual subject. This virtual subject will be used as a
computational model to guide the selection of personalized treatment regimens for the
training of executive functions in children with ADHD. The virtual Time Management task
requires the use of a working memory function composed of a convolutional neural
network trained to identify handwritten digits in the MNIST dataset, as well as an
impulsivity function that produces impulsive responses. Recurrent neural networks trained
to output sequences of integers that are factors of the number 12 are used to represent a
simplified fluid intelligence function. Thus, the virtual Time Management task that was
developed required this first version of a virtual subject to use both a working memory
function, hindered by an impulsivity function that produces impulsive responses, and a
fluid intelligence function for its successful completion. The remainder of this chapter will
first address general limitations of the computational models, then describe the
development of each executive function model in more detail, and conclude with a
discussion of approaches to improve the translational applicability of the computational
model to human subjects and the progress of the TVG pilot study.
The overall design of this project is limited in two important ways. First, it is
unlikely that a therapeutic video game intervention will be sufficient for addressing the full
scope of impairments present in ADHD. The executive function theory for ADHD has not
proven to be a complete description of the neuropsychological impairments present in this
disease. A meta-analysis investigating the likelihood of executive function deficits being
the primary cause of ADHD found that these deficits were not present in all the study’s
subjects, and their presence only exerted a moderate effect size on ADHD symptoms167.
Executive function deficits in ADHD have also proven to be heterogeneous in nature, and
inhibition deficits are not present in every patient168. Notably, this latter finding is contrary
to Barkley’s proposal of a central deficit in inhibition being responsible for the
development of ADHD7. Taken together, these results indicate that executive function
deficits are neither necessary nor sufficient to cause the development of ADHD.
Furthermore, new multiple pathways theories have emerged that incorporate executive
function deficits as a single pathway together with an excessive motivation to avoid
delays169 and temporal processing deficits170. Therefore, the targeting of executive function
impairments alone will not be an effective approach for the treatment of ADHD.
Even if the targeting of executive function deficits does not prove to be a method
to correct the full scope of impairments in ADHD, this strategy may nonetheless be of use
to improve the functioning of children with ADHD. In addition, the personalized treatment
strategy of the therapeutic video games intervention remains an advantageous approach to
address a heterogeneous set of impairments such as those in ADHD due to the highly
individualized treatment recommendations it may prove to offer. The flexibility of the
Minecraft environment would also permit the development of additional tasks to target
neuropsychological deficits in non-executive function domains.
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Secondly, while the artificial neural networks used in the computational model of
executive function deficits bear some similarity to biological neural networks, they
nonetheless remain a profoundly simplified approximation. A complete discussion of these
simplifications is beyond the scope of this work, but a few illustrative limitations are worth
pointing out here.
The most significant limitation of artificial neural networks as a model for
neurological activity may be their simplified representation of the structure and function of
biological neural networks. Although the design of a single feed-forward network with
multiple layers may resemble the structure of a biological network composed of multiple
neurons working in tandem, this kind of network might more closely resemble the
structural complexity of an individual branch of a dendritic tree in a single neuron171. As a
result, even the largest artificial neural network models in use would not be capable of
achieving computational complexity that a single neuron is capable of producing.
An important functional simplification in artificial neural networks is the exclusion
of spatial and temporal information from their design172. Whereas the spatial distribution
of input signals to the dendritic tree of a biological neuron is an important factor for the
processing of these inputs, this factor is not accounted for in commonly used artificial
neural networks. Furthermore, the functioning of the current generation of artificial neural
networks relies on the rate code approximation, which means that all the inputs and outputs
in a network model are represented as average firing rates of electrical impulses in
synapses. In contrast, biological neurons interpret the patterns of input signals they receive
and convey important information in the patterns of the output signals they produce.
New generations of artificial neural networks currently under development hold
promise for the amelioration of the functional limitations in the current generation of
network models. For example, spiking neural networks are designed to more accurately
model the temporal function of real neurons, and are currently under development as a
computational tool for widespread use173. Spiking neural networks utilize differential
equations to incorporate temporal input information as biological neural networks do, but
their use is currently limited by difficulties in their training procedures. These, and other
neural networks systems under development, may increase the computational power of
artificial neural networks over time to improve their capability to model the function of
biological neural networks more accurately.
5.1

Working Memory

Working memory is defined as the ability to hold information in consciousness
(short-term memory) and manipulate it2. This definition leads to the rationalization for the
use of image identification by convolutional neural networks as a model for working
memory. In the current implementation, the input of an MNIST image file into the first
layer of the network is proposed to represent the holding of information in consciousness
component of working memory, and the subsequent processing of this input data by the
internal network layers is proposed to represent the manipulation component of working
memory.
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The input of data into the network as the short-term memory component of working
memory admittedly is not a strong representation of this mental ability for two reasons.
First, the data provided as input to the convolutional neural network is the actual MNIST
example data itself, so there is no recall mechanism to produce an internal representation
of this MNIST example data in its absence. Second, there is no holding mechanism to
maintain this internal representation of the data over time to allow its manipulation. Thus,
the working memory function could be improved through the addition of data recall and
holding mechanisms to the convolutional neural network. The recall mechanism would
operate prior to the input of data to the convolutional neural network, while the holding
mechanism would operate simultaneously with the processing of the input data in each
hidden layer of the convolutional neural network. These modifications could potentially
improve the resemblance of this working memory function to the function of working
memory in biological neural networks by including a simplified representation of the
biological short-term memory component while maintaining a manageable level of
computational complexity.
Although several neural network models have been proposed to represent the shortterm memory component of working memory174, a degree of redundancy may exist in the
actual biological neural networks that are responsible for this executive function so no
single computational process is responsible for biological working memory in all cases175.
Two examples of artificial neural network models for modeling biological working
memory include cell assemblies and synfire chains. Cell assemblies176 consist of strongly
interconnected groups of neurons in a Hopfield model that maintain a persistent excitation
pattern over time through their mutual activation. Here, the outputs of a given group of
neurons at one instance in time is used as the input for this same group of neurons in the
next instance to produce a recurrent firing pattern. The excitation pattern maintained by
cell assemblies is a representation of a piece of information held in short-term memory,
and this model relies on the use of the leaky-integrator differential equation to model the
temporal dynamics of input currents and firing rates of individual neurons. Synfire
chains177 also rely on the leaky-integrator differential equation to model their temporal
dynamics, but use a feedforward neural network model rather than a recurrent Hopfield
model. While the standard feedforward neural networks have the individual neurons in
each layer firing at varying rates, individual groups of neurons/layers in synfire chains all
fire simultaneously in time, and produce a persistent chain of spikes across multiple layers
that represent the piece of information held in short-term memory. These models have been
developed from the biophysical properties of individual neurons’ dynamic function, and
therefore attempt to capture a level of complexity that is too great for the purposes of this
project at this time. Nevertheless, much of this complexity may be obviated with the
selection and design of simpler models that ignore these temporal dynamics of neural
function while still representing similar functions.
To represent the recall mechanism of short-term memory, an autoassociative
memory linear associator network trained by supervised Hebbian Learning9 could be
utilized. This type of network could potentially be trained to produce an MNIST image as
an output when similar MNIST images are presented as inputs. With proper training, the
output of such networks would provide accurate representations of MNIST images, even
when provided with a corrupted version of a given image as its input. Hence, a properly
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trained network with an effective recall would reproduce high-quality MNIST images as
outputs when provided with altered MNIST images as inputs, whereas a poorly trained
network with an ineffective recall would produce poor-quality MNIST images as outputs.
These reproduced versions of MNIST images would then be provided as inputs to the
manipulation function represented by convolutional neural networks in the current
implementation of the working memory model. The high-quality MNIST images produced
by well-trained linear associator networks with effective recall would enable more effective
performance of the manipulation function represented by convolutional neural networks
and result in a higher probability of a correct handwritten digit identification and more
effective use of working memory as a whole. In contrast, the low-quality MNIST images
produced by poorly-trained linear associator networks with ineffective recall would impede
the performance of the manipulation function represented by convolutional neural
networks and result in a lower probability of a correct handwritten digit identification and
less effective use of working memory as a whole.
One potential approach to represent the holding mechanism of short-term memory
is to interfere with the passage of information between individual layers of the
convolutional neural network during the operation of the manipulation function. Although
the original input data is transformed with each passage from layer to layer, it can still be
considered a modified representation of the original information and therefore the act of
transferring the output from one layer as an input to the next layer could be considered
analogous to holding the information being manipulated. Within this context, a
dysfunctional holding mechanism could be represented with an ineffective transfer of
information between layers (by randomly corrupting the data values before they are input
into a layer, for example) and an effective holding mechanism could be represented by an
unimpeded transfer of information between layers.
5.2

Impulsivity & Inhibition

The design of the impulsivity function was influenced by both the race model and
the passive-dissipation hypothesis for the control of impulsive behavior. These theories
have been used to explain the results observed in the stop-signal task, which is a behavioral
task requiring the use of inhibitory control. Both of these theories describe impulsive
responses and their inhibition in terms of mental processes that grow in strength over time
and compete to reach a threshold value that activates a behavioral response. These theories
differ in the mechanism of impulsive behavior prevention, as the passive-dissipation
hypothesis includes an active role for inhibitory control (described below). The impulsivity
function in the current project was designed to represent the mental processes that compete
to produce behavioral responses as described in these theories. However, the role of the
impulsivity function at this time is the generation of impulsive behaviors rather than their
inhibition, although the design of an inhibitory control component that works as described
in the passive-dissipation hypothesis remains to be addressed in future work.
The race model has been used to describe the mental processing of prepotent
responses and their inhibition in the stop signal task177. Prepotent responses are a category
of behavioral responses to stimuli for which immediate reinforcement is presently available
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or has been available in the past, and were identified as a target for the behavioral inhibition
executive function in Barkley’s influential executive function theory for ADHD7.
Prepotent responses can be overlearned behaviors, occur impulsively without reflection,
and can oftentimes conflict with long-term goals. All individual trials in the stop signal
task contain a “go” signal that requires the experimental subject to select a response. A
subset of these trials also include the presentation of a “stop” signal at varying time
intervals after the “go” signal has been presented, and require the experimental subject to
withhold the selection of a response. The presentation of the “stop” signal after the “go”
signal is significant in that the mental processing for responding to the “go” signal is
already active when the “stop” signal is presented. The race model proposes that these
processes are independent and compete to produce a behavioral response, and the resulting
behavioral response is activated by the process that reaches a given threshold more rapidly
in time.
The passive-dissipation hypothesis178 builds on the race model by allowing the
prepotent response to be overcome by the use of the executive function of inhibition to
create a delay in the decision to respond. This delay allows the slower correct response to
continue growing in strength to reach the response threshold as the prepotent response
dissipates. While the use of the executive function inhibition is not included in this project,
the impulsivity function was designed to allow for the use of inhibition to create a delay in
the decision to respond. When this delay occurs the slower mental process for an
appropriate response grows in strength and exerts a greater influence on the decisionmaking process.
The impulsivity function was developed to produce prepotent responses during the
operation of the working memory function as the convolutional neural network identifies
handwritten digits in the shuffled MNIST test set. The prepotent responses are generated
by the impulsivity function when multiple examples of MNIST images are encountered in
a row during the operation of the working memory function. Every time a subsequent
image containing the same digit as the previously encountered image is presented as an
input to the convolutional neural network, positive reinforcement is provided for a correct
response to that digit and the strength of the prepotency for this response grows. Then,
when an image containing a different handwritten digit is encountered, this previously
reinforced prepotent response may be activated and lead to an incorrect response. The
likelihood of activation of the prepotent response may be reduced by an executive function
response, however, and the prevailing behavioral response is determined by the relative
strength of these two competing responses.
The impulsivity function attempts to model the mental processes that compete to
produce either impulsive behaviors or more carefully considered productive behaviors.
This initial implementation of the impulsivity function is limited to a prepotent response
(PR) process curve and an executive function (EF) process curve. These mental process
curves are generated from a strength parameter, efficiency parameter, and delay parameter.
The strength parameter determines the size of the curve’s peak, the efficiency parameter
determines how rapidly the curve reaches its peak, and the delay parameter indicates the
time delay from presentation of the stimulus to when the mental process curve initiates. A
behavioral response is determined by subtracting the value of the EF process curve from
the value of the PR process curve at the decision point to produce a prepotent response
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probability (PRP). The PRP is then compared to a randomly generated value between 0 &
1 (RV). If the PRP is greater than RV a prepotent response is initiated, otherwise a nonimpulsive response is initiated.
Importantly, the EF process curve described above represents the application of a
set of executive function processes that are distinct from the behavioral inhibition executive
function. The EF process curves are dedicated towards the creation of productive
behaviors, whereas the behavioral inhibition executive function is dedicated towards the
delay of the decision point to allow these EF process curves to overcome the opposition of
the PR process curve that activates unproductive, impulsive behavior. In this example, the
EF process curve represents the strength of the mental process that activates the use of
working memory through a trained convolutional neural network to identify a handwritten
digit, while the PR process curve represents the strength of the mental process that bypasses
the use of working memory in the formation of a response that is less likely to be correct.
The addition of a behavioral inhibition executive function in future implementations of the
impulsivity function would delay the decision point and thus allow for the EF process curve
to grow in strength while the PR process curve weakens. As a result, the PRP would
decrease and the likelihood of the initiation of a productive behavior would increase.
Similar to the impulsivity function, both the race model and passive-dissipation
hypothesis describe impulsive behaviors and their inhibition in terms of competing mental
processes. However, while the race model and passive-dissipation hypothesis define this
competition as a race in time between mental processes to reach a given threshold value,
the impulsivity function defines this competition in terms of the relative magnitudes of the
outputs of the mental processes. In other words, the race model and passive-dissipation
hypothesis describe the resulting behavioral response as an outcome of only one of the
mental processes, while the impulsivity function defines the behavioral response as an
outcome of an interaction between both mental processes. In the race model the winning
process is simply the process which reaches the threshold first, while in the passivedissipation hypothesis the winning process is the one which reaches the threshold when the
decision to act is made. In contrast, the impulsivity function implements the resulting
behavioral response as the outcome of an interaction between both of the mental processes
by subtracting the strengths of the outputs of the mental processes.
This initial implementation of the impulsivity function was designed to create
impulsive responses to interfere with the operation of the working memory function in the
absence of any influence from behavioral inhibition. Thus, the current version of the
impulsivity function simply defines the decision point as the time when the PR process
curve reaches its peak value, which is when the PR process exerts its maximum effect on
the behavioral response and the EF process exerts a relatively minor effect. However, a
behavioral inhibition delay parameter may be added in future implementations of the
impulsivity function to create a delay of the decision point to allow for the PR process to
weaken as the EF process strengthens, leading to a greater opportunity for the application
of a productive behavioral response as reflected in a decreased PRP value.
Two alternative computational methods that have been used for modeling inhibition
are the negative bias weight learning mechanism and the drift-diffusion model. The
negative bias weight learning mechanism179 was applied within the context of a dynamic
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gating neural network model for a task-switching activity similar to the Wisconsin card
sorting task, which is a psychological test used to measure cognitive flexibility180. The
dynamic gating model utilizes a feedforward network with a single hidden layer that is
connected to another layer representing the pre-frontal cortex. This pre-frontal cortex layer
learns representations of the various rules governing appropriate responding in the task. As
the task proceeds, the active rule changes and the neural network’s pattern of responding
must also change accordingly to avoid making erroneous responses resulting from the
previously active rule. The negative bias weight learning mechanism inhibits responses
from the previous rule by rapidly decreasing the values of the weights for the units
representing this previous rule to a large negative value, making these units inactive. These
weights are then allowed to gradually return to increase to zero as the task continues to lift
the inhibition. The negative bias weight learning mechanism operates within the context of
the continuous training of a neural network as it performs a given task. In contrast, the
impulsivity function operates as an external precursor to the CNNs in this model, and
therefore the negative bias weight learning mechanism would not be compatible with this
current approach.
A potential alternative method for the computational modeling of behavioral
inhibition processes is the drift diffusion model181. The drift diffusion model has garnered
interest in computational psychiatry to model decision-making processes182, and the
parameters of this model have been linked to neural functions183-186. It has been utilized for
the modeling of decision-making processes in two-choice decision tests181, including tests
measuring inhibitory control, such as the go/no-go task183 and the stop-signal task187. In the
case of the go/no-go task, the drift-diffusion model was used to analyze reaction time data
in subjects with ADHD to compare predictions between theories of ADHD188-189, while the
capability of the model to represent the results of a rational decision-making process
involving Bayesian inference was investigated in the case of the stop-signal task187.
The drift diffusion model has been useful for modeling simple one- or two-choice
decisions183, where the selection of a decision is determined by one or more stochastic drift
processes that move towards boundaries representing the available decisions. The
stochasticity in the model is incorporated through the addition of random noise to the
movement of the drift processes as they travel towards a boundary. When the movement
of the drift process reaches one of the boundaries, a decision to complete the action
represented by that boundary is made.
The drift diffusion model consists of the following parameters: a start point (z), the
boundary separation (a), the drift rate (v), and non-decision process time (ter). After a time
delay representing the encoding of a stimulus, the start point z is reached. The start point z
may be located closer to one or the other of the boundaries, depending on an individual’s
expectations of the correct response in the decision making task. The distance between the
boundaries representing each decision is represented by the boundary separation a, which
is determined the amount of information required by an individual to make a decision and
the individual’s decision-making strategy, such as a speed-accuracy trade-off. For
example, an individual with a greater concern for accuracy than speed would require a
greater amount of information before making a decision, and a greater boundary separation
would result. In contrast, an individual with a greater concern for speed than accuracy
would require less information to make a decision and possess a smaller separation between
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the boundaries representing their decisions in this model. The drift rate v represents the
rate at which the sensory information required for an individual to make a decision
accumulates, and is affected by the individual’s level of arousal. In the case of an individual
with low arousal, such as a subject with ADHD for example, this information would
accumulate more slowly and a longer time would be required for this individual to make a
decision than an individual with higher arousal. Finally, the non-decision process time ter
represents the times required for the encoding of the stimulus before the drift process
initiates and for the motor processing of the behavior representing the decision after the
drift process is completed.
In the case of the Go/No-Go task where the inhibition of a prepotent response is
considered, there would be two possible decisions (go and no-go) represented by two
boundaries and a single drift process that ends when one of these boundaries is reached.
However, in the case of the stop-signal task where the inhibition of an ongoing response is
considered, there are two drift processes that occur. The first of these is similar to the single
drift process of the Go/No-Go task that proceeds towards one of two decision boundaries,
while the second represents the additional inhibition process that must be initiated to
prevent the ongoing response. This second drift process begins later in time than the initial
drift process representing the mental processing of the decision that must be inhibited; the
drift process that is completed sooner in time activates the decision to respond or not to
respond, as described in the race model.
In contrast to the negative bias weight learning mechanism described earlier in this
section, the drift-diffusion model offers a viable alternative for the representation of
impulsive behaviors and their inhibition currently offered by the impulsivity function.
While the drift-diffusion model has a stronger record of evidence for its use, to our
knowledge its application has been limited to the modeling of decision-making in simple
one- or two-choice decision-making tasks. A complex gaming environment such as
Minecraft, however, presents dynamic decision-making scenarios where more choices may
be available at any given moment and choices are continuously removed or added as
circumstances change. It is foreseeable that higher complexity environments could present
decision-making scenarios that require alternative criteria for inhibitory decision-making
that extend beyond the time-based processing of alternatives by the drift-diffusion model.
Therefore, the use of multiple inhibitory decision-making models may be advantageous in
this project to determine whether different models may work more effectively in different
varieties of decision-making scenarios.
5.3

Fluid Intelligence

The Factorization of 12 task using basic RNNs to output factor sets of the number
12 was used as a representation for the synthesis component of fluid intelligence in this
experiment. This task can be improved by the inclusion of a representation for the process
of analysis to create a more comprehensive model of fluid intelligence and by adopting a
different variety of RNN to increase the complexity of the task. Consider the process of
analysis (breaking down complex ideas) as the inverse of the process of synthesis (building
up complex ideas). When the process of synthesis is then represented as the building up of
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the “complex” number 12 from its simpler component factors, the process of analysis may
be represented as the breaking down of the number 12 into its simpler component factors.
Thus, the fluid intelligence operation that currently consists of the process of synthesis will
be expanded to include an RNN task to break down the number 12 as a representation for
the process of analysis.
In the current version of the task, the RNN begins by producing a factor of the
number 12, which is then used as an input in the next loop of the task for the RNN to output
another factor. This process continues until the RNN produces an output to indicate the end
of the sequence of factors and then concludes with an evaluation of the accuracy of the
sequence. The reverse process can be implemented through the modification of the RNN’s
training set. The training set will be differentiated into two separate categories, where one
category consists of factor sequences with factors ordered from smallest to largest in size
and vice-versa for the other category. The training set with examples ordered by increasing
size of their factors will train RNNs for the process of synthesis (where the larger number
is assembled), while the training set with examples ordered by decreasing size will train
RNNs for the process of analysis (where the larger number is broken down).
An additional improvement is the substitution of the basic RNNs with Long-Short
Term Memory networks (LSTMs). While basic RNNs indiscriminately update every
parameter of their internal layer with each step of the sequence they produce, LSTMs
include additional “forget” gates in this updating process that screen for and exclude the
passage of extraneous information to the internal layer between steps in the sequence. This
increased efficiency of updating permits the processing of larger sequences in LSTMs, and
thus LSTMs would be beneficial to permit the analysis and synthesis of larger numbers in
this project. The capability to process larger numbers in this way would allow the creation
of multiple difficulty levels for the task to more accurately capture the properties of the
therapeutic video games tasks which have multiple difficulty levels.
A comparison of this work to alternative modeling approaches is difficult due to a
paucity of research related to the neural functions that produce fluid intelligence. The
function of a network of brain regions known collectively as the Multiple-Demand System
has been proposed to play a general role across multiple complex problem solving tasks in
primates190. Detailed functional neural network theories are lacking however. While a
recent theory has proposed that fluid intelligence results from a widespread, randomly
connected network structure of groups of neurons6, to our knowledge there does not seem
to be any research available that examines the computations that these types of networks
conduct.
5.4

Translation to Human Subjects

The translational applicability of this model to the treatment of executive function
deficits in humans with ADHD could be improved with the development of an assessment
tool, similar to the NICHQ assessment used in the clinical pilot study, to measure
simplified ADHD-like behaviors in the virtual “subjects”. The NICHQ is completed by
parents and teachers who observe a child with ADHD, so the assessment tool for the
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computational model will also be completed by trained observers who will monitor the
actions of the virtual “subjects”. With the inclusion of this virtual “NICHQ” tool, the
changes in performance resulting from modifications in the training procedures of the
ANNs would be determined not only by their final performance on a complex virtual
activity, but also their “behavior” as they complete the activity.
To increase the translational applicability of the virtual “NICHQ”, its assessment
questions will be designed to be as similar as possible to the questions of the actual NICHQ
in humans. Many of the behaviors measured by the NICHQ involve the interaction of a
child with their peers and environment. To simulate these interactive behaviors, it will be
necessary to develop an interactive environment for the ANNs. One potential method to do
so would be to program the ANNs to function within the Minecraft environment itself that
is used as the platform for the therapeutic video game executive function training activities.
In fact, CNNs have been trained with reinforcement learning to function in Minecraft191.
However, a simpler approach to implement would be to continue using the supervised
learning approach in this model, but create an environment with multiple virtual “subjects”
working side-by-side by parallelizing the computations to run across multiple processors
simultaneously in a cloud environment. This way, the current implementation of the model
could still be used to produce an interactive environment with the creation of additional
functions to enable interactions between the ANNs of multiple virtual “subjects”.
5.5

Clinical Pilot Study

At the present moment, the progress of the clinical pilot study of the TVG
intervention has been slower than expected due to difficulties with patient recruitment. To
accelerate the progress of recruitment, a contract research organization (CRO) was hired
to manage the operations of the clinical study. However, further consideration of the nature
of the patient recruitment difficulties may be instructive as a source of guidance for the
improvement of the therapeutic video game intervention for future clinical studies.
One potential reason for these recruitment difficulties is the complexity of the study
intervention. The study group completing the video game intervention requires an
investment of 150 minutes of Minecraft game play per week (Section 3.1.2.2), which may
require a larger commitment than ADHD patients and their parents are willing to agree to.
In addition to recruitment difficulties, a complicated treatment intervention could also lead
to problems with compliance and high subject dropout rates. While the development of a
computational optimization method to streamline the TVG training schedule could
ameliorate some of the intervention’s complexity, this treatment intervention will still
require a greater investment of effort to complete than a pharmacological intervention.
To ameliorate potential problems with compliance even further, a parental
involvement component could be added to the intervention. This component could
encourage the participation of parents in a supportive coaching role, and include parent
training to improve the quality of the interactions with their child. The inclusion of
psychosocial interventions targeting parents is an effective treatment for children with
ADHD193, and has been found to enhance the effects of working memory training193.
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Furthermore, positive parental and family interactions have shown protective effects
against the development of ADHD in cross-sectional and longitudinal studies54-59. Thus,
modifying the therapeutic video game intervention to increase parental involvement could
prove to be an effective strategy to increase treatment compliance and efficacy.
5.6

Conclusion

An orphan drug indication for a drug/device combination of stimulants with the
online game Minecraft to train executive function deficits is being pursued for the treatment
of ADHD-like symptoms in Fragile X Syndrome. This intervention will utilize a novel
personalized medicine approach where an individualized treatment regimen consisting of
an initial stimulant dose recommendation and schedule of therapeutic video game activities
will be determined from the initial ADHD assessment results of new patients. In the model,
a set of ANNs will first be trained to resemble the pattern of executive function deficits
reflected in a new patient’s assessment responses. A large set of virtual tasks resembling
the therapeutic video game activities will be tested in the model, and the set of virtual tasks
that produces the maximum improvements in the ANNs of the virtual “subject” will predict
the analogous set of therapeutic video game tasks most beneficial for the human patient.
The translational efficacy of this computational optimization method to human subjects
will then be determined in a future clinical study where an experimental group completing
a computationally optimized executive function activity training schedule is compared to
a control group that completes a generic, non-optimized executive function activity training
schedule. This application of ANNs as a guide for optimization of clinical study
interventions and individualized therapy recommendations is a novel use of computational
approaches to save time and expense in a clinical development process and improve the
medical treatment of patients with ADHD.
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